title: micro-dissected cells [JC49]

city: Utrecht

first: Jean-Charles

last: Boisset

address: Uppsalalaan 8

country: Netherlands

institute: Hubrecht Institute

description: E13 fetal liver small structure dissection to single-cells

data_processing:
Raw data files for single-cell samples contain data for 96 multiplexed cells. Raw data for bulk samples contain data for 2000 cells processed in bulk in a single library. The column number containing the data in the bulk sample processed data refers to the barcode ID. Cell-specific bar codes are available in the file cel-seq_barcodes.csv on the series record.
Paired end reads obtained by CEL-seq were aligned to the transcriptome using bwa (version 0.6.2-r126) with default parameters. The transcriptome contained all RefSeq gene models based on the mouse genome release mm10 downloaded from the UCSC genome browser and contained 31,109 isoforms derived from 23,480 gene loci. All isoforms of the same gene were merged to a single gene locus. The right mate of each read pair was mapped to the ensemble of all gene loci. Reads mapping to multiple loci were discarded. The left read contains the barcode information: the first eight bases correspond to a sample specific barcode. The remainder of the left read contains a polyT stretch followed by few (<15 transcript derived bases).
When indicated, reads were mapped to a modified RefSeq with inserted CAST/EiJ SNPs
Genome_build: mm10
Supplementary_files_format_and_content: *.gene.coutt.csv: Tab separated data file for each sequencing library, listing all genes (rows) and the number of sequenced transcripts for all samples. Column name indicate the cell number of the experiment, separated by a space. The first column lists the official gene symbol followed by the chromosome name, separated by a double underscore.

extract_protocol:
Cells were directly placed into Trizol (Life Technologies) and total RNA was isolated according to the manufacturer’s instructions, with the following alterations. RNA was precipitated overnight at -20 °C, with 2.5µg GlycoBlue (Life Technologies).
RNA was processed using the previously described CEL-seq technique, with the indicated modifications. Libraries were sequenced on an Illumina NextSeq500 using 75bp paired end sequencing.

value: Fetal liver


title: sorted cells [JV8BM7]

status: Public on Nov 01 2017

type: SRA

description: Bone marrow single-cells

library_source: transcriptomic

molecule: total RNA

organism: Mus musculus

source_name: Bone marrow single-cells

tag: strain

tag: tissue

value: Bone marrow


title: micro-dissected cells [JC58_Bl6_and_Cast]

description:
Bone marrow small structure dissection to single-cells mapped to mm10 refseq and to a modified RefSeq containing the CAST/EiJ SNPs:
The JC57 and JC58 experiments are control experiments where we mixed, in a 1:1 ratio, bone marrow cells from two genetically different strains of mice (C57Bl/6 and CAST/EiJ). In the case of JC57 and JC58, because we blindly sampled cells that could be either from the C57Bl/6 or CAST/EiJ strain, we mapped the raw reads to both the classical RefSeq (mm10, based on C57Bl/6, here corresponding to the processed files JC57_Bl6.coutt.csv and JC58_Bl6.coutt.csv), and to a modified RefSeq containing the CAST/EiJ SNPs (here corresponding to the processed files JC57_Cast.coutt.csv and JC58_Cast.coutt.csv).

value: Mixed C57Bl/6 and CAST/EiJ


title: sRNA_Seq_E14_d25.1_DNMT1KO

city: Cambridge

first: Felix

last: Krueger

address: Granta Park

department: Bioinformatics

country: United Kingdom

institute: Altos Labs

data_processing:
small RNASeq: Raw FastQ data were trimmed with Trim Galore (v0.3.5, default parameters) and mapped to the mouse NCBIM37 genome assembly using Bowtie2 (version 2.2.9). Data were quantitated at gene level using the read count enrichment over genes correcting for reads per million and read length  in SeqMonk software (www.bioinformatics.babraham.ac.uk/projects/seqmonk/).
Genome_build: NCBIM37
Supplementary_files_format_and_content: Quantitated RNA-Seq data file is tab delimited and contains the following 89 columns: (1) gene name; (2) Chromosome; (3) Start; (4) End; (5) Strand; (6-89) RPKM values of each sample

extract_protocol:
RNA was isolated using TriReagent (Sigma) and treated with DNAseI (Ambion DNA-free DNA Cat #1311027) using manufacturers instructions
smallRNASeq: 10-1000ng RNA was used for library preparation using Illumina small RNA Library Prep Kit v2 (Illumina) following the manufacturer’s instructions. Libraries were indexed using Illumina smallRNA Indexes and 50 bp single-end or paired-end sequencing was performed on Illumina HiSeq 2000 or Miseq instruments using TruSeq reagents (Illumina, San Diego, CA, USA), according to manufacturer’s instructions.

tag: background strain

tag: cell type

value: ESC

tag: genotype

value: Dnmt1 KO


title: sorted cells [JV4BM3]

description: Bone marrow single-cells


title: sorted cells [JV8BM6]

description: Bone marrow single-cells


title: micro-dissected cells [JC53]

description: E15 fetal liver small structure dissection to single-cells


title: sorted cells [JV6BM5]

description: Bone marrow single-cells


title: micro-dissected cells [JC54]

description: E14 fetal liver small structure dissection to single-cells


title: mmu_FUS_RiboProf_hFUSR495X_1

city: Baltimore

first: Manolis

last: Maragkakis

state: MD

address: 251 Bayview Blvd

country: USA

institute: National Institute on Aging

description: ribosome protected RNA fragment

data_processing:
Library strategy: Ribo-seq
CLIP-Seq and Ribo-Seq adapter trim: the adaptor sequences were trimmed from the reads using cutadapt (v1.12). The adaptor AGGGAGGACGATGCGG was trimmed from the 5’-end of reads and GTGTCAGTCACTTCCAGCGGTCGTATGCCGTCTTCTGCTTG was trimmed from the 3’-end allowing for 0.25 error rate. Only reads longer than 15-nt after adaptor trimming were retained. RNA-Seq adapter trim: The adaptor sequences were trimmed from the reads using the cutadapt software in paired-end mode. The adaptor AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC was trimmed from the 3’-end of mate 1 reads and AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA was trimmed from the 3’-end of mate 2 reads allowing for 0.25 error rate.
CLIP-Seq and Ribo-Seq read alignment: reads were aligned to the mouse genome (mm9) using the STAR aligner (v2.4.1c) and the following parameters --outFilterMultimapScoreRange 0 --alignIntronMax 50000 --outFilterIntronMotifs RemoveNoncanonicalUnannotated --outFilterMatchNmin 15 --outFilterMatchNminOverLread 0.9 --sjdbOverhang 100. Reads mapping to areas annotated by RepeatMasker as ribosomal RNAs or tRNAs were excluded from further analysis. RNA-Seq read alignment: Paired-end alignment was performed using STAR with the same parameters as for CLIP and Ribo-Seq.
Aligned reads were loaded into a SQLite3 database for further processing with CLIPSeqTools (v0.1.7) and annotated with information whether they overlap with elements from RepeatMasker (downloaded from UCSC) and genes (from UCSC gene model annotation file).
Gene counts were measured using CLIPSeqTools
Genome_build: mm9
Supplementary_files_format_and_content: Processed files are TAB delimited files quantifying the number of reads in each gene. Files contain the following columns: gene_name, gene_location, gene_length, gene_count, gene_count_per_nt, gene_exonic_count, gene_exonic_length, gene_exonic_count_per_nt, gene_intronic_count, gene_intronic_length, gene_intronic_count_per_nt

source_name: Neurons

growth_protocol: Mouse embryonic stem cells (ES, E14Tg2A.4) were maintained in ES medium on gelatinized plates without feeder cells. Neuronal differentiation was performed as described previously (Wichterle et al., 2009). Cells were maintained into ADFNB+GDNF.

extract_protocol:
For CLIP samples, UV crosslinked RNA bound to the exogenous protein was isolated from immunoprecipitated sample with anti-FLAG antibody (CellSignaling, #2368). For RNA-seq, total RNA was isolated from cells expressing exogenous protein and ribosomal and transfer RNA were depleted with Ribo-Zero Gold kit (Illumina). For Ribo-seq, the ribosome protected RNA fragment (RPF) between 25 to 35 nt in size were collected from cells expressing exogenous protein according to a previous report (Ingolia NT et al, Nat Protc. 2012).
For CLIP-seq, library preparation was performed as described in Nakaya et al, RNA, 2013. Briefly, protein bound RNA was ligated with a 3'-linker with biotin by T4 RNA ligase and then treated with T4 PNK (NEB) and extracted from protein. Then, a 5'-linker was ligated and amplified by RT-PCR. For RNA-seq, total RNA was prepared as above and the library was prepared using TruSeq Stranded mRNA LT Sample Prep Kit (Illumina). For Ribo-seq, Ribosome protected fragments (RPFs) were used as input and library was prepared as described in the RNA-seq library preparation in Nakaya et al, RNA, 2013. Briefly, a 3'-linker with biotin was ligated to the RPFs and purified with streptoavidin attached beads and then a 5'-linker was ligated on the beads. Following several wash, the RNA on beads was used for RT-PCR as template. The following sequences need to be trimmed from raw reads: For CLIP-Seq and Ribo-Seq "GTGTCAGTCACTTCCAGCGGTCGTATGCCGTCTTCTGCTTG" needs to be trimmed from the 3'end. For RNA-Seq "AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC" and "AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA" needs to be trimmed from the 3'end of read 1 and read 2 respectivelly.

treatment_protocol: NFLAG-hFUSWT or NFLAG-hFUSR495X were expressed in ES cell derived neurons by lentivirus system and cells were treated with DOX to induce expression of the exogenous protein along with Geneticin to select the cells infected with virus. Control cells had no treatment.

value: ES cell derived neurons

tag: molecule type

value: ribosome protected RNA fragment

tag: lentiviral transfuction

value: FLAG-tagged human R495X


title: micro-dissected cells [JC55]

source_name: E13 fetal liver small structure dissection to single-cells


title: sorted cells [JV6BM7]

description: Bone marrow single-cells


title: sorted cells [JV8BM5]

description: Bone marrow single-cells


title: micro-dissected cells [JC57_Bl6_and_Cast]

source_name: Bone marrow small structure dissection to single-cells mapped to mm10 refseq


title: HUVEC-GROseq-oxPAPC

city: Kuopio

first: Minna

middle: U

last: Kaikkonen

department: A.I. Virtanen Institute, Department of Biotechnology and Molecular Medicine

country: Finland

institute: University of Eastern Finland

description: nascent RNA

data_processing:
Library strategy: GRO-Seq
Libraries were sequenced for 50 cycles on an Illumina HiSeq 2000 according to the manufacturer’s instructions.
GRO-Seq results were trimmed to remove A-stretches originating from the library preparation using the Homer software (homerTools trim) and from resulting sequences those shorter than 25 bp were discarded. Sequence reads were further quality filtered with the FASTX software (-q 10 -p 97)
GRO-seq reads were aligned to the hg19 genome assembly using Bowtie version 0.12.9 (-v 2 -k 3 -m 1 --best)
Genome_build: hg19
Supplementary_files_format_and_content: bedGraphs

organism: Homo sapiens

source_name: human umbilical vein endothelial cells

growth_protocol: HUVECs were purchased from Life Technologies. HUVECs were maintained in Endothelial Cell Growth medium (EGM; 0.1% human epidermal growth factor, 0.1% hydrocortisone, 0.1% Gentamicin - Amphotericin-B, 0.4% bovine brain extract, 2% FBS; Lonza) on cell culture flasks coated with 10 g/ml fibronectin (Sigma, St. Louis, MO) and 0.05 % gelatin in PBS.

extract_protocol:
Nuclei were extracted from 5-10 million cells and nuclear run-on reactions were performed for 5 minutes at 30°C in the presence of Sarkosyl and BrUTP. RNA was extracted with Trizol-LS.
The RNA was base-hydrolyzed, dephosphorylated with PNK and purified using RNA Clean & Concentrator kit (Zymo). Poly(A)-tailing was followed by cDNA synthesis using complementary poly(T)-primers containing Illumina adapter sequences. Excess oligo was removed by Exonuclease I and cDNA fragments of were purified using ChIP DNA Clean & Concentrator kit. The recovered cDNA was RNaseH treated and circularized (CircLigase) and amplified for 13 cycles. The final product was ran on 10% TBE gel, gel purified (200-350 bp) and cleaned-up using ChIP DNA clean & Concentrator Kit.

value: human umbilical vein endothelial cells

tag: passage

value: passage 10

tag: treatment

value: oxPAPC 6h


title: HUVEC-GROseq-ctrl

description: nascent RNA

value: control


title: mmu_FUS_RiboProf_hFUSWT_1

description: ribosome protected RNA fragment


title: mmu_FUS_RiboProf_CTRL_1

description: ribosome protected RNA fragment

value: wild type FUS


title: mmu_FUS_CLIP_hFUSWT_1

description: FUSWT bound RNA

data_processing:
CLIP-Seq and Ribo-Seq adapter trim: the adaptor sequences were trimmed from the reads using cutadapt (v1.12). The adaptor AGGGAGGACGATGCGG was trimmed from the 5’-end of reads and GTGTCAGTCACTTCCAGCGGTCGTATGCCGTCTTCTGCTTG was trimmed from the 3’-end allowing for 0.25 error rate. Only reads longer than 15-nt after adaptor trimming were retained. RNA-Seq adapter trim: The adaptor sequences were trimmed from the reads using the cutadapt software in paired-end mode. The adaptor AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC was trimmed from the 3’-end of mate 1 reads and AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA was trimmed from the 3’-end of mate 2 reads allowing for 0.25 error rate.
CLIP-Seq and Ribo-Seq read alignment: reads were aligned to the mouse genome (mm9) using the STAR aligner (v2.4.1c) and the following parameters --outFilterMultimapScoreRange 0 --alignIntronMax 50000 --outFilterIntronMotifs RemoveNoncanonicalUnannotated --outFilterMatchNmin 15 --outFilterMatchNminOverLread 0.9 --sjdbOverhang 100. Reads mapping to areas annotated by RepeatMasker as ribosomal RNAs or tRNAs were excluded from further analysis. RNA-Seq read alignment: Paired-end alignment was performed using STAR with the same parameters as for CLIP and Ribo-Seq.
Aligned reads were loaded into a SQLite3 database for further processing with CLIPSeqTools (v0.1.7) and annotated with information whether they overlap with elements from RepeatMasker (downloaded from UCSC) and genes (from UCSC gene model annotation file).
Gene counts were measured using CLIPSeqTools
Genome_build: mm9
Supplementary_files_format_and_content: Processed files are TAB delimited files quantifying the number of reads in each gene. Files contain the following columns: gene_name, gene_location, gene_length, gene_count, gene_count_per_nt, gene_exonic_count, gene_exonic_length, gene_exonic_count_per_nt, gene_intronic_count, gene_intronic_length, gene_intronic_count_per_nt

tag: antibody

value: anti-FLAG antibody (CellSignaling, #2368)

value: FUSWT bound RNA


title: Huh-IP

city: minneapolis

first: Liang

last: Guo

state: MINNESOTA

address: 2001 6th Street SE

institute: University of Minnesota

description: IP using anit-NS5A antibody

data_processing:
Basecalls performed using CASAVA.
Sequencing reads were trimmed using trimmomatic 2.0, and trimmed reads were mapped to the human genome (hg19) using Bowtie 2.0 with default settings.
Tophat (v2.0.13) and Cufflinks (v2.2.1) were used subsequently to generate Fragments Per Kilobase of transcript per Million (FPKM) mapped reads.
Transcript decay rates were determined following addition of actinomycin D based on a model of first order decay.
Genome_build: hg19
Supplementary_files_format_and_content: A matrix table includes FPKM values for each sample (Tab-delimited text files)

source_name: hepatoma cells

growth_protocol: Huh and Huh-HCV cells were propagated in Dulbecco’s modified eagle’s medium (DMEM, Gibco) supplemented with 10% FBS (Atlanta biologicals), 0.1 mM nonessential amino acids (Gibco), 1% L-Glutamine (Gibco) and 100 units/ml of penicillin/streptomycin (Gibco).  For Huh-HCV cells, 500 µg/mL of G418 (Calbiochem) was added to the medium.

extract_protocol:
RNA was purified from the immunoprecipitated material using the RNeasy kit (Qiagen) following manufacturer’s instructions.
RNA libraries were prepared for sequencing using standard Illumina protocols

treatment_protocol: Actinomycin D (5 µg/mL, Sigma) was added to the media, and cells were collected after 0, 3 and 6 hours. RNA-IP was performed using a rabbit polyclonal antibody for NS5A.

tag: cell line

value: human hepatoma cell line Huh 7.5

value: IP using anit-NS5A antibody

tag: virus status

value: without HCV subgenomic replicon


title: Huh-HCV-3h

description:
2 technical replicates seqencing files merged
cells were 3h after adding Actinomycin D

value: Huh 7.5 SI cell line

tag: agent

value: Actinomycin D

tag: time point

value: with HCV subgenomic replicon


title: Huh-3h


title: ESC_HiC_TKO_Rep2

first: Yixian

last: Zheng

address: 3520 San Martin Drive

department: Embryology

institute: Carnegie Institution for Science

library_source: genomic

data_processing:
All RNA-seq samples were sequenced on an Illumina Hi-Seq 2000 using paired-end 100-bp mode. The resulting paired-end reads were trimmed to 75-bp paired-end reads as the last 25 bp had low sequencing quality. Then the reads were then mapped to the mouse genome mm9 using Tophat 2.1.0 (Kim et al., 2013a), and we used the Gencode gtf file (vM1) as known transcripts (-G option). We used htseq-count (Anders et al., 2015) to count reads on genes defined by the Gencode gtf file. Only genes in the “lincrna” and “protein coding” types were considered.
Chip-seq libraries were sequenced on an IlluminaHi-seq 2000 with single-end 50-bp mode. The reads were mapped to the mm9 genome using Bowtie 1.1.2 (Langmead et al., 2009) with "-v 2 -m 1" option. Bedgraph files for genome browser view were generated using custom script.
For HiC data, trimming, mapping, pair-matching and filtering were done using the HiCUP software (Wingett et al., 2015), The interaction read number beween each two 20-Kb windows are counted.
Genome_build: mm9
Supplementary_files_format_and_content: tab-delimited text file showing counts of RNA-seq reads on each gene
Supplementary_files_format_and_content: gzipped bedgraoh file showing ChIP-seq read density (RPKM)
Supplementary_files_format_and_content: tab-delimited text file showing interaction read counts between each two 20-Kb windows.

molecule: genomic DNA

source_name: embryonic stem cells

growth_protocol: The derivation of wild-type and lamin-TKO mESCs were described in our previous publication (Kim et al., 2013b). WT and TKO mESCs were cultured using the same method as described (Kim et al., 2013b) for Hi-C, ChIP-seq, and RNA-seq experiments. For FISH, mESC stocks, which were prepared from the mESCs expanded on feeder cells, were thawed and grown using 0.1% gelatin-coated plates in the absence of feeder cells with KO-DMEM medium (Invitrogen) containing 15% fetal bovine serum (FBS, Invitrogen), 100 μM β-mercaptoethanol (Invitrogen), 2 mM Glutamax, 0.1 mM nonessential amino acids, 50 μg/ml penicillin/streptomycin, and 1,000 units/ml LIF (Millipore). When the cells became ~70% confluent, they were passaged to a new plate and incubated for 30 min at 37°C in 5% CO2 to allow the attachment of the residue feeder cells to the bottom of the plate.

extract_protocol:
WT or TKO mESCs were cultured in feeder-free condition as described (Kim et al., 2011). Five to eight million feeder-free mESCs were harvested and resuspended in 10 ml basal culture medium [10% FBS, 100 µM beta-mercaptoethanol (Life Technologies), 2 mM L-glutamine, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, and 50 µg/ml penicillin/streptomycin in GMEM (Life Technologies)]. Cells were fixed with 1% formaldehyde for 10 min at room temperature. After fixation, formaldehyde was quenched by adding 125 mM glycine. The cells were incubated at RT for 5 min, followed by an additional incubation on ice for 15 min. The cells were centrifuged at 1,000g for 10 min, and the cell pellets were washed with ice-cold 1x PBS.The crosslinked cell pellet was resuspended and lysed in Hi-C lysis buffer [10mMTris, pH8.0; 10 mM NaCl; 0.2% IGEPAL CA-630 (NP-40);1xprotease inhibitor cocktail (Roche, 04693132001)], rotating at 4oC for 30 min. The lysed cells were centrifuged at 1,000 g for 5 min. The pellet was washed with 1ml ice-cold 1.2x NEBuffer 3.1 (NEB, B7203S), and then resuspended in 0.4 ml 1.2x NEBuffer 3.1. To remove uncrosslinked proteins, 6 μl 20% SDS were added, followed by incubation at 65oC for 10 min. 40 μl 20% Triton X-100 were added to quench SDS and mixed carefully by inverting several times. The suspension was incubated at 37oC for 10 min. To digest the crosslinked chromatin, 30 μl 50 units/μl BglII enzyme (NEB, R0144M) were added to the suspension. The enzyme reactant was incubated overnight at 37oC.To mark the cohesive ends generated by BglII with biotin, 1.5 μl 10 mM dATP, 1.5 μl 10 mM dGTP, 1.5 μl 10 mM dTTP (Qiagen), 3.0 μl 5 mM biotin-16-dCTP (Axxora, JBS-NU-809-BIO16) and 10 μl 5 units/μl Klenow (NEB, M0210L) were added. The mixture was incubated at 37oC for 45 min, and then placed on ice. The blunted chromatin DNA was ligated by adding 750 μl 10x T4 ligase buffer (NEB, B0202S), 75 μl 10 mg/ml BSA (NEB), 6151.5 μl distilled water, and 30 μl 30 units/μl T4 DNA ligase (Thermo Scientific, EL0013). A total of 7.5 ml ligation mixture was incubated overnight at 16oC.To reverse crosslinking, 25 μl 20 mg/ml proteinase K (Life Technologies, 25530-049) was added and incubated overnight at 65oC. After cooling at RT, 10 ml phenol (pH 8.0) were added to the suspension, and vigorously mixed by vortexing for 2 min. The suspension was centrifuged for 5 min at 3,500 rpm with a standard tabletop centrifuge. The aqueous phase was mixed with 10 ml phenol:chloroform (1:1). After centrifugation, the supernatant was transferred to a 50 ml Oak Ridge centrifuge tube (Nalgene) and the total volume was brought to 10 ml with 1x TE (pH 8.0). To precipitate the ligated DNA, 1 ml 3M sodium acetate, 5 μl 15 mg/ml GlycoBlue (Life Tech, AM9515), and 10 ml isopropanol were added, and mixed by inverting. The mixture was incubated at -80oC for at least 1 h. The suspension was centrifuged at 38,000 g, 4oC for 30 min. The precipitated pellet was resuspended in 450 μl 1x TE (pH 8) and the suspension was transferred to an 1.5 ml Eppendorf tube. DNA was extracted with 500 μl phenol:chloroform (1:1). After phenol:chloroform extraction, 40 μl 3M sodium acetate, 1 μl GlycoBlue, and 1 ml 100% ethanol were added to the supernatant, and incubated at -80oC for 30 min. To precipitate DNA, the suspension was centrifuged at 18,000 g for 20 min. The pellet was washed with 70% ethanol and then air dried completely. The dried pellet was resuspended in 45 μl 10 mM Tris (pH 8.0). DNA concentration was determined using a Quant-iTdsDNA assay kit (Life Tech, 33120).  5 g DNA was used for the next step.5 g DNA was mixed with 10 μl 10x NEBuffer 2.1, 12.5 μl 10 mM dNTP mix (Qiagen, 201900), 1.6 μl 3 units/μl T4 DNA polymerase (NEB, M0203S), and the total reaction volume was brought to 100 μl with distilled water. The mixture was incubated at 12oC for 2 h. The 3’-5’ exonuclease activity of the T4 DNA polymerase degraded the un-ligated biotinylated DNA. The reaction was stopped by adding 2 μl 0.5 M EDTA. DNA was purified with a QIAquick PCR purification kit (Qiagen), eluting with 50 μl 10 mM Tris (pH 8.0).  To bind biotinylated DNA to streptavidin beads, 30 μl Dynabeads MyOne Streptavidin C1 (Life Technologies, 65501) were washed and resuspended in 50 μl 2x binding buffer (10 mM Tris, pH 8.0, 0.1 mM EDTA, 2 M NaCl), 50 μl biotinylated DNA was added, and the mixture was incubated at RT for 30 min, constantly mixing with an Intelli mixer (Cole Parmer, UX-51202-22) or an equivalent. After washing with 1x binding buffer (10 mM Tris, pH 8.0, 0.1 mM EDTA, 1 M NaCl) and 1x NEBuffer 4.1, the beads were resuspended in 50 μl 1x NEBuffer 4.1. To trim biotinylated DNA into small fragments, 1μl 10 units/μl AluI (NEB, R01317S) was added and incubated at 37oC for 60 min. After AluI digestion, the beads were subsequently washed with 1x binding buffer and 10 mM Tris (pH 8.0), and resuspended in 16 μl 10 mM Tris (pH 8.0).
To ligate paired-end Illumina sequencing adaptors to the AluI digested DNA fragments, beads were processed with NEBNext® DNA Library Prep Reagent Set (NEB, E6000S) as follows: For dA-tailing, the beads in 16 μl 10 mM Tris (pH 8.0) were mixed with 2.5 μl 10x NEBuffer 2, 5.0 μl dATP, 1.5 μl Klenow (all included in the NEB kit), and incubated at 37oC for 30 min; constant agitation is not required hereafter. dA-tailed beads were washed with 1x binding buffer, and resuspended in 5.0 μl 10 mM Tris (pH 8.0). To ligate sequencing adaptors, the beads in 5.0 μl 10 mM Tris (pH 8.0) were mixed with 12.5 μl ligation reaction buffer, 5.0 μl NEBNext adaptor, and 2.5 μl Quick T4 ligase (all included in the NEB kit), and incubated at 20oC for 15 min. To cleave the hairpin loop of NEBNext adaptors, 1.5 μl USER enzyme (included in the NEB kit) were added and incubated at 37oC for 15 min. The beads were washed with 1x binding buffer and resuspended in 10 μl of 10 mM Tris (pH 8.0). To amplify adaptor ligated DNA, the beads in 10 μl of 10 mM Tris (pH 8.0) were mixed with 1.25 μl Universal PCR primer, 12.5 μl PCR master mix (included in the NEB kit), 1.25 μl of NEBNext Indexed primer (NEB, E7500S), and the PCR was performed with the following program (98oC 30 sec, 8 cycles of [98oC 10 sec, 65oC 30 sec, 72oC 30 sec], and 72oC 5min). PCR amplified Hi-C library DNA was purified with AMPure XP magnetic beads (Beckman Coulter). The quality of Hi-C library DNA was assessed with a Bioanalyzer (Agilent, 2100). Successful Hi-C library DNA ranged from 200 bp to 1 kb in size with a clear single peak at about 600 bp.

value: ESC

value: lamin-B1/B2/A triple knockout


title: Huh-6h

description:
2 technical replicates seqencing files merged
cells were 6h after adding Actinomycin D


title: ESC_HiC_WT_Rep2

value: wildtpye


title: Huh-HCV-IP

description: IP using anit-NS5A antibody


title: Huh-0h

description:
2 technical replicates seqencing files merged
cells were collected 0h after adding Actinomycin D


title: Huh-HCV-0h

description:
2 technical replicates seqencing files merged
cells were 0h after adding Actinomycin D


title: CFI68_R2

city: Irvine

first: Elmira

last: Forouzmand

state: CA

address: B228 Medical Science I

department: Department of Microbiology and Molecular Genetics

institute: University of California Irvine

data_processing:
Reads with a string of As (at least 15) were trimmed and kept. These reads were mapped to human genome (hg9), using TopHat v2.1.0 with the setting -g 1.
Alignmnet with the possibility of internal priming were removed if a read had 6 or more consecutive As or more than 7 As in the 10 nucleotide downstream of polyA site.
Bigwig files were generated from the remaing reads, using deepTools 2.4
From the remaing reads those with their 3' end in the interval of -40nt to +40nt of potential polyA sites were used to generate the count table.
Genome_build: hg19
Supplementary_files_format_and_content: bigwig files, and tab-delimited text files include read counts for polyA sites for each Sample

source_name: CFIm68 knockout cell line 2 (HEK293T)

growth_protocol: Cells were grown in DMEM + 5% FBS at 37 °C with 5% CO2

extract_protocol:
Total RNAs from all cell lines were extracted using Trizol reagent following manufacturer's instruction.
Total RNA was extracted with Trizol as per manual (Life technologies), 10 μg total RNA was fragmented with fragmentation reagent (Ambion) at 70 oC for 10 minutes followed by precipitation with ethanol. After centrifugation, RNA was dissolved and Reverse transcription was performed with PASSEQ7-2 RT oligo : [phos]NNNNAGATCGGAAGAGCGTCGTGTTCGGATCCATTAGGATCCGAGACGTGTGCTCTTCCGATCTTTTTTTTTTTTTTTTTTTT[V-Q] and Superscript III. cDNA was recovered by ethanol precipitation and centrifugation. 120-200 nucleotides of cDNA was gel-purified and eluted from 8% Urea-PAGE. Recovered cDNA was circularized with CircligaseTM II (Epicentre) at 60 oC overnight. Buffer E (Promega) was added in cDNA and heated at 95 oC for 2 minutes, and then cool to 37 oC slowly. Circularized cDNA was linearized by adding BamH I (Promega). cDNA was centrifugated after ethanol precipitation. PCR was carried out with primers PE1.0 and PE2.0 contaning index. Around 200 bp of PCR products was gel-purified and submitted for sequencing (single read 100 nucleotides).

treatment_protocol: CFIm59 and CFIm68 KO cells were generated in HEK293T cells using CRISPR/Cas9 system.

tag: genotype/variation

value: CFIm68 knockout


title: CFI68_R1

source_name: CFIm68 knockout cell line 1 (HEK293T)


title: U2004

city: Århus N

first: Trine Line

middle: Hauge

last: Okholm

address: Palle Juul-Jensens Boulevard 99

department: Department of Molecular Medicine (MOMA)

country: Denmark

institute: Aarhus University Hospital

description: processed data file: circ_cell_line_expression_CPM.tab

data_processing:
Fastq base calling was performed with configureBclToFastq.pl v1.17 for the Hiseq runs and bcl2fastq v 2.16.0.10. Both from Illumina.
Mapping to hg19 was performed with bowtie2 v2.2.8
Bowtie was ran with the following settings: "--very-sensitive --phred33 --mm --score-min=C,-15,0" and candidate circRNAs were found in the unmapped output using the following settings "--reorder --mm --score-min=C,-15,0" and custom scripts from the Rajewsky Lab (unmapped2anchors.py, sum.py and scorethresh.py).
Expression values of circRNAs were normalized within the study.
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include CPM (Counts per Million) values for each circRNA in each sample

source_name: cell line

growth_protocol:
J82 cells were propagated in MEM media (Gibco, Life Technologies) with 1% non-essential amino acids (Gibco, Life Technologies) and 2% L-Glutamine (Gibco, Life Technologies)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)

extract_protocol:
RNA was extracted with miRNeasy mini kit according to the manufacturer’s instructions (Qiagen)
The Dynabeads mRNA DIRECT Micro Kit (Ambion, Life Technologies) was used for selection of poly(A) transcripts followed by library preparation using ScriptSeq (Epicentre).

value: urinary bladder

value: metastatic

tag: fraction

value: all


title: 293T

value: wild type control


title: U2011

growth_protocol:
HT1376 cells were propagated in MEM media (Gibco, Life Technologies) with 1% non-essential amino acids (Gibco, Life Technologies) and 2% L-Glutamine (Gibco, Life Technologies)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)


title: U2009

growth_protocol:
UMUC3 cells were propagated in MEM media (Gibco, Life Technologies) with 1% non-essential amino acids (Gibco, Life Technologies) and 1mM Sodium Pyrovat (Life Technologies)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)


title: CFI59_R2

source_name: CFIm59 knockout cell line 2 (HEK293T)

value: CFIm59 knockout


title: U2008

growth_protocol:
T24 cells were grown in McCoy’s 5A media (Gibco, Life Technologies, Carlsbad, CA, USA)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)


title: U2001

growth_protocol:
FL3 cells were grown in DMEM/F12 media (Gibco, Life Technologies) with 2% L-glutamine (Gibco, Life Technologies)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)


title: U2002

growth_protocol:
HCV29 cells were grown in DMEM (Gibco, Life Technologies)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)

value: non-malignant


title: U2005

growth_protocol:
Nhutert cells were propagated in Keratinocyte-SFM, with Recombinant Epidermal Groth Factor (2,5µg/500 ml) (ThermoFisher Scientific) and 0.05% Bovine Pituitary Extract (Life Technologies)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)

value: Nhutert


title: U2003

growth_protocol:
HT1197 cells were propagated in MEM media (Gibco, Life Technologies) with 1% non-essential amino acids (Gibco, Life Technologies) and 1mM Sodium Pyrovat (Life Technologies)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)


title: ES_WT_LDN_2

city: Shanghai

first: Xiaobai

last: Zhang

address: 1239 Siping Road

country: China

institute: Tongji University

data_processing:
RNA-seq reads were aligned to the UCSC human genes (hg19) using Tophat (version 2.0.13). Only the uniquely mapped reads were retained for analysis in this study.
We used Cuffdiff (version 2.2.1) to calculate the expression abundance of each gene as reads per kilobase per million mapped reads (RPKM).
Supplementary_files_format_and_content: The processed data file is a tab-delimited file showing gene expresssion levels with RPKM.

source_name: hES

growth_protocol: Human ES line was cultured on irradiated mouse embryonic fibroblasts according to the standard protocol which can be found at http://www.wicell.org.

extract_protocol:
hES cells RNA was harvested using Trizol reagent. Illumina TruSeq RNA Sample Prep Kit (Cat#FC-122-1001) was used with 1 ug of total RNA for the construction of sequencing libraries.
RNA libraries were prepared for sequencing using standard Illumina protocols.

treatment_protocol: ES_WT_LDN  group was treated with 1UM LDN for 4 days.

tag: cell

value: hES

value: wild type +LDN


title: ES_WT_LDN_1

tag: strain


title: Huh-HCV-6h


title: ES_WT_2

value: wild type


title: ES_WT_LDN_3


title: CFI59_R1

source_name: CFIm59 knockout cell line 1 (HEK293T)


title: U2006

growth_protocol:
RT4 cells were grown in McCoy’s 5A media (Gibco, Life Technologies, Carlsbad, CA, USA)
For all cell lines (except Nhutert) the culture media was supplemented with 10% Fetal Calf Serum (FCS) (Gibco, Life Technologies) and 1% Penicillin-Streptomycin (Gibco, Life Technologies). Cells were cultured at 37°C in an atmosphere of 5% CO2. Cell line authentication was confirmed using Cell-ID (Promega, Fitchburg, WI, USA)

tag: tissue


title: KO_2


title: ES_WT_3


title: WT_3


title: ES_WT_1


title: KO_1


title: KO_3


title: WT_2


title: RWPE1_HiC_rep1

city: Los Angeles

first: Zhifei

last: Luo

address: 1450 Biggy Street, NRT 6514

institute: University of Southern California

description:
RWPE1_comb_HiC_5k.raw.matrix.txt
RWPE1_comb_HiC_40k.raw.matrix.txt

data_processing:
RNA-seq data was inspected by FastQC and trimmed using Trimmomatic version 0.35. Reads were mapped to human genome GRCh37 using STAR version 2.5.2b with default settings.
Alignment results were processed for gene quantification using featureCounts version 1.5.1 with the strand-specific option
Differentially expressed genes were determined using DESeq2 version 1.14.1
TPM values for each gene were calculated by RSEM v1.3.0
The quality of each Hi-C library was checked with FastQC and HICUP version 0.5.842. Raw fastq files were processed through the HiC-Pro version 2.8.0 to make the raw contact count matrices for multiple resolutions (5kb, 10kb, 20kb, 40kb, 100kb). The matrices were normalized using the iterative correction method (iced python library). For the identification of topologically associating domains (TADs), the normalized Hi-C contact matrices, binned with 40kb resolution were used and the domains were called using the Domain caller. Intra-chromosomal significant loops (50kb-10Mb range) were selected with the 5kb resolution contact count matrices using the Fit-Hi-C (false discovery rate (FDR) < 0.05). Hi-C chromatin interaction heatmaps with 5kb resolution was visualized in the 3D Genome Browser (http://biorxiv.org/content/early/2017/02/27/112268). To increase the sequencing depth, two replicates were pooled and processed as above described.
Genome_build: GRCh37
Supplementary_files_format_and_content: TPM values and differential expression; Hi-C contact matrices

growth_protocol: RWPE-1 cells were cultured in Keratinocyte Serum Free Medium (Thermo Fisher Scientific, cat. no. 17005-042) without antibiotics. To passage the cells, 0.05% trypsin-0.02% EDTA solution was used and the trypsinization was stopped by adding Dulbecco's phosphate-buffered saline containing 2% FBS. Cells were grown at 37 °C with 5% CO2 for under 20 passages. The cell line identity was confirmed using the STR cell line authentication method at the Norris Comprehensive Cancer Center Media Core and was shown to be free of mycoplasma using the universal mycoplasma detection kit (ATCC 30-1012K).

extract_protocol:
RNA was prepared using TRIzol reagent (Thermal Fisher Scientific, cat. no. 15596018). In situ Hi-C experiments were performed in RWPE-1 cells following the original protocol by Rao et al with minor modifications. Hi-C was performed in duplicate and 5 x 106 cells were used for each experiment. 100U of MboI restriction enzyme (NEB, R0147) was used to digest chromatin. For ligation, 2000U T4 DNA Ligase (NEB, M0202) was added and incubated at room temperature for 4 hours with slow rotation. Hi-C material was sheared to a size of 300-500bp using a Covaris instrument (Covaris S2, Woburn, MA). Biotin-tagged DNA was pulled down using Dynabeads MyOne Streptavidin C1 beads (Life technologies, 65002) with 2X Binding Buffer (2X BB: 10mM Tris-HCl (pH 7.5), 1nM EDTA, 2M NaCl). Hi-C library was amplified with 14 cycles of PCR using Illumina primers. Each library was sequenced with 75bp paired-end for ~500M read pairs using Illumina HiSeq 2000.
The RNA-seq libraries were made using KAPA stranded mRNA-seq kits (KAPK Biosystems, cat. no. kk8421) according to manufacturer’s instructions
In situ HiC experiments were performed in RWPE-1 cells following the original protocol by Rao et al with minor modifications. HiC was performed in duplicate and 5 x 106 cells were used for each experiment. 100U of MboI restriction enzyme (NEB, R0147) was used to digest chromatin. For ligation, 2000U T4 DNA Ligase (NEB, M0202) was added and incubated at room temperature for 4 hours with slow rotation. HiC material was sheared to a size of 300-500bp using a Covaris instrument (Covaris S2, Woburn, MA). Biotin-tagged DNA was pulled down using Dynabeads MyOne Streptavidin C1 beads (Life technologies, 65002) with 2X Binding Buffer (2X BB: 10mM Tris-HCl (pH 7.5), 1nM EDTA, 2M NaCl). HiC library was amplified with 14 cycles of PCR using Illumina primers.

treatment_protocol: For overexpression, RWPE-1 cells were transfected with equal amounts of a HOXA13 expression vector (GeneCopoeiaTM cat. no. EX-I0919-M14) or the corresponding control plasmid expressing eGFP (GeneCopoeiaTM cat. no. EX-EGFP-M14) and harvested 48 hours later. Cells were analyzed by FACS to identify GFP-positive cells and the top 10% eGFP positive cells from 3 control and 3 HOXA13-expressing flasks were collected by cell sorting and subjected to RNA isolation, followed by RNA-seq analysis.

value: prostate cell line RWPE1


title: WT_1


title: S9_week_4-TB Subjects-140724_I269_FCC4N24ACXX_L4_RHUMjlxTAAAPRAAPEI-227

city: Seattle

first: Daniel

last: Zak

state: WA

address: 188 East Blaine Street, Suite 300

institute: Regeneron

data_processing:
Alignment STAR version STAR_2.3.1d
Sequenced reads were filtered for low-quality sequence and the presence of 'N's, then mapped to hg19 whole genome STAR_2.3.1d
Junctions counts were calculated by using an in house script to count the number of reads mapped to all splice junctions in the genome
Gene counts were calculated by usingHTSEQ to map the read counts to the gene names
Genome_build: hg19
Supplementary_files_format_and_content: tab delimited file including the raw junction counts for all the detected junctions in the genome (number of reads mapped to the splice junctions in all samples)
Supplementary_files_format_and_content: tab delimited file including the raw gene counts for all the detected genes in the genome

source_name: Blood

extract_protocol:
Paxgene RNA
GlobinClear Globin transcript reduction followed by Illumina mRNA-Seq

value: blood

tag: subject

tag: disease state

value: TB Subjects

tag: treatmentresult

value: Definite Cure

tag: time

tag: timetonegativity

tag: mgit

tag: xpert

tag: tgrv


title: S9_week_4-TB Subjects-140726_I232_FCC4NA4ACXX_L1_RHUMjlxTAAAPRAAPEI-227


title: S9_week_24-TB Subjects-140726_I232_FCC4NA4ACXX_L1_RHUMjlxTAAAQRAAPEI-201


title: S9_week_24-TB Subjects-140724_I269_FCC4N24ACXX_L4_RHUMjlxTAAAQRAAPEI-201


title: S9_day_7-TB Subjects-140726_I232_FCC4NA4ACXX_L1_RHUMjlxTAAAORAAPEI-225


title: S9_DX-TB Subjects-140726_I232_FCC4NA4ACXX_L1_RHUMjlxTAAANRAAPEI-223

value: DX


title: S9_day_7-TB Subjects-140724_I269_FCC4N24ACXX_L4_RHUMjlxTAAAORAAPEI-225


title: S9_DX-TB Subjects-140724_I269_FCC4N24ACXX_L4_RHUMjlxTAAANRAAPEI-223


title: S99_week_24-TB Subjects-140805_I272_FCC4MTNACXX_L4_RHUMjlxTAAGZRABPEI-223


title: S99_week_24-TB Subjects-140805_I272_FCC4MTNACXX_L3_RHUMjlxTAAGZRABPEI-223


title: S99_week_4-TB Subjects-140805_I272_FCC4MTNACXX_L3_RHUMjlxTAAGYRABPEI-222


title: S99_DX-TB Subjects-140805_I272_FCC4MTNACXX_L4_RHUMjlxTAAGWRABPEI-220


title: S99_day_7-TB Subjects-140805_I272_FCC4MTNACXX_L3_RHUMjlxTAAGXRABPEI-221


title: S99_DX-TB Subjects-140805_I272_FCC4MTNACXX_L3_RHUMjlxTAAGWRABPEI-220


title: S98_week_4-TB Subjects-140815_I175_FCC4MVKACXX_L8_RHUMjlxTAAGURBAPEI-218


title: S98_week_24-TB Subjects-140805_I272_FCC4MTNACXX_L1_RHUMjlxTAAGVRABPEI-219


title: S98_week_4-TB Subjects-140815_I175_FCC4MVKACXX_L7_RHUMjlxTAAGURBAPEI-218


title: S98_week_24-TB Subjects-140805_I272_FCC4MTNACXX_L2_RHUMjlxTAAGVRABPEI-219


title: S98_DX-TB Subjects-140805_I272_FCC4MTNACXX_L2_RHUMjlxTAAGSRABPEI-215


title: S98_DX-TB Subjects-140805_I272_FCC4MTNACXX_L1_RHUMjlxTAAGSRABPEI-215


title: RWPE1_HiC_rep2

tag: cell line

tag: treatment


title: S95_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L7_RHUMjlxTAAGQRABPEI-213


title: S98_day_7-TB Subjects-140805_I272_FCC4MTNACXX_L2_RHUMjlxTAAGTRABPEI-216


title: S95_week_24-TB Subjects-140805_I272_FCC4MTNACXX_L2_RHUMjlxTAAGRRABPEI-214


title: S98_day_7-TB Subjects-140805_I272_FCC4MTNACXX_L1_RHUMjlxTAAGTRABPEI-216


title: S95_week_24-TB Subjects-140805_I272_FCC4MTNACXX_L1_RHUMjlxTAAGRRABPEI-214


title: S95_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L8_RHUMjlxTAAGQRABPEI-213


title: S99_day_7-TB Subjects-140805_I272_FCC4MTNACXX_L4_RHUMjlxTAAGXRABPEI-221


title: S95_DX-TB Subjects-140805_I272_FCC4T1PACXX_L8_RHUMjlxTAAGORABPEI-211


title: S99_week_4-TB Subjects-140805_I272_FCC4MTNACXX_L4_RHUMjlxTAAGYRABPEI-222


title: S95_day_7-TB Subjects-140805_I272_FCC4T1PACXX_L8_RHUMjlxTAAGPRABPEI-212


title: S95_day_7-TB Subjects-140805_I272_FCC4T1PACXX_L7_RHUMjlxTAAGPRABPEI-212


title: S95_DX-TB Subjects-140805_I272_FCC4T1PACXX_L7_RHUMjlxTAAGORABPEI-211


title: S93_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L6_RHUMjlxTAAGMRABPEI-209

value: Probable Cure


title: S93_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L4_RHUMjlxTAAGMRABPEI-209


title: S93_week_24-TB Subjects-140805_I272_FCC4T1PACXX_L7_RHUMjlxTAAGNRABPEI-210


title: S93_DX-TB Subjects-140805_I272_FCC4T1PACXX_L4_RHUMjlxTAAGKRABPEI-207


title: S93_day_7-TB Subjects-140805_I272_FCC4T1PACXX_L6_RHUMjlxTAAGLRABPEI-208


title: S93_day_7-TB Subjects-140805_I272_FCC4T1PACXX_L4_RHUMjlxTAAGLRABPEI-208


title: S93_DX-TB Subjects-140805_I272_FCC4T1PACXX_L6_RHUMjlxTAAGKRABPEI-207


title: S92_week_24-TB Subjects-140805_I272_FCC4T1PACXX_L6_RHUMjlxTAAGJRABPEI-206


title: S92_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L2_RHUMjlxTAAGIRABPEI-205


title: S92_day_7-TB Subjects-140805_I272_FCC4T1PACXX_L2_RHUMjlxTAAGHRABPEI-204


title: S92_day_7-TB Subjects-140805_I272_FCC4T1PACXX_L3_RHUMjlxTAAGHRABPEI-204


title: S92_DX-TB Subjects-140815_I175_FCC4MVKACXX_L1_RHUMjlxTAAGGRBAPEI-203


title: S91_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L2_RHUMjlxTAAGERABPEI-201


title: S91_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L3_RHUMjlxTAAGERABPEI-201


title: S92_week_24-TB Subjects-140805_I272_FCC4T1PACXX_L4_RHUMjlxTAAGJRABPEI-206


title: S91_week_24-TB Subjects-140805_I272_FCC4T1PACXX_L2_RHUMjlxTAAGFRABPEI-202


title: S91_day_7-TB Subjects-140815_I175_FCC4MVKACXX_L7_RHUMjlxTAAGDRBAPEI-227


title: S91_day_7-TB Subjects-140815_I175_FCC4MVKACXX_L8_RHUMjlxTAAGDRBAPEI-227


title: S90_week_4-TB Subjects-140815_I175_FCC4MVKACXX_L4_RHUMjlxTAAGARBAPEI-222


title: S91_DX-TB Subjects-140815_I175_FCC4MVKACXX_L4_RHUMjlxTAAGCRBAPEI-225


title: S93_week_24-TB Subjects-140805_I272_FCC4T1PACXX_L8_RHUMjlxTAAGNRABPEI-210


title: S90_week_24-TB Subjects-140815_I175_FCC4MVKACXX_L6_RHUMjlxTAAGBRBAPEI-223


title: S90_week_24-TB Subjects-140815_I175_FCC4MVKACXX_L4_RHUMjlxTAAGBRBAPEI-223


title: S90_day_7-TB Subjects-140815_I175_FCC4MVKACXX_L4_RHUMjlxTAAFZRBAPEI-221


title: S90_DX-TB Subjects-140815_I175_FCC4MVKACXX_L2_RHUMjlxTAAFYRBAPEI-220


title: S92_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L3_RHUMjlxTAAGIRABPEI-205


title: S89_week_4-TB Subjects-140815_I175_FCC4MVKACXX_L2_RHUMjlxTAAFWRBAPEI-218


title: S89_week_4-TB Subjects-140815_I175_FCC4MVKACXX_L3_RHUMjlxTAAFWRBAPEI-218


title: S89_week_24-TB Subjects-140815_I175_FCC4MVKACXX_L3_RHUMjlxTAAFXRBAPEI-219


title: S92_DX-TB Subjects-140812_I270_FCC4N2DACXX_L8_RHUMjlxTAAGGRBAPEI-203


title: S89_DX-TB Subjects-140815_I175_FCC4MVKACXX_L1_RHUMjlxTAAFURBAPEI-215


title: S91_week_24-TB Subjects-140805_I272_FCC4T1PACXX_L3_RHUMjlxTAAGFRABPEI-202


title: S90_week_4-TB Subjects-140815_I175_FCC4MVKACXX_L6_RHUMjlxTAAGARBAPEI-222


title: S88_week_4-TB Subjects-140804_I270_FCC4RL0ACXX_L8_RHUMjlxTAAFSRABPEI-213


title: S88_week_4-TB Subjects-140805_I272_FCC4T1PACXX_L1_RHUMjlxTAAFSRABPEI-213


title: S89_day_7-TB Subjects-140815_I175_FCC4MVKACXX_L3_RHUMjlxTAAFVRBAPEI-216


title: S88_week_24-TB Subjects-140815_I175_FCC4MVKACXX_L1_RHUMjlxTAAFTRBAPEI-214


title: S89_day_7-TB Subjects-140815_I175_FCC4MVKACXX_L2_RHUMjlxTAAFVRBAPEI-216


title: S89_DX-TB Subjects-140812_I270_FCC4N2DACXX_L8_RHUMjlxTAAFURBAPEI-215


title: S88_DX-TB Subjects-140804_I270_FCC4RL0ACXX_L8_RHUMjlxTAAFQRABPEI-211


title: S88_day_7-TB Subjects-140804_I270_FCC4RL0ACXX_L8_RHUMjlxTAAFRRABPEI-212


title: S88_DX-TB Subjects-140805_I272_FCC4T1PACXX_L1_RHUMjlxTAAFQRABPEI-211


title: S90_DX-TB Subjects-140815_I175_FCC4MVKACXX_L3_RHUMjlxTAAFYRBAPEI-220


title: S87_week_24-TB Subjects-140804_I270_FCC4RL0ACXX_L8_RHUMjlxTAAFPRABPEI-210


title: S87_week_24-TB Subjects-140805_I272_FCC4T1PACXX_L1_RHUMjlxTAAFPRABPEI-210


title: S88_day_7-TB Subjects-140805_I272_FCC4T1PACXX_L1_RHUMjlxTAAFRRABPEI-212


title: S88_week_24-TB Subjects-140812_I270_FCC4N2DACXX_L8_RHUMjlxTAAFTRBAPEI-214


title: S87_DX-TB Subjects-140801_I162_FCC4T6AACXX_L3_RHUMjlxTAAFNRAAPEI-208


title: S87_DX-TB Subjects-140730_I284_FCC4N7JACXX_L3_RHUMjlxTAAFNRAAPEI-208


title: S87_day_7-TB Subjects-140815_I175_FCC4MVKACXX_L1_RHUMjlxTAAFORBAPEI-209


title: S87_day_7-TB Subjects-140812_I270_FCC4N2DACXX_L8_RHUMjlxTAAFORBAPEI-209


title: S91_DX-TB Subjects-140815_I175_FCC4MVKACXX_L6_RHUMjlxTAAGCRBAPEI-225


title: S89_week_24-TB Subjects-140815_I175_FCC4MVKACXX_L2_RHUMjlxTAAFXRBAPEI-219


title: S86_DX-TB Subjects-140730_I284_FCC4N7JACXX_L2_RHUMjlxTAAFKRAAPEI-205


title: S86_day_7-TB Subjects-140801_I162_FCC4T6AACXX_L2_RHUMjlxTAAFLRAAPEI-206


title: S86_week_24-TB Subjects-140730_I284_FCC4N7JACXX_L3_RHUMjlxTAAFMRAAPEI-207


title: S90_day_7-TB Subjects-140815_I175_FCC4MVKACXX_L6_RHUMjlxTAAFZRBAPEI-221


title: S86_day_7-TB Subjects-140730_I284_FCC4N7JACXX_L2_RHUMjlxTAAFLRAAPEI-206


title: S85_week_24-TB Subjects-140730_I284_FCC4N7JACXX_L2_RHUMjlxTAAFJRAAPEI-204


title: S86_DX-TB Subjects-140801_I162_FCC4T6AACXX_L2_RHUMjlxTAAFKRAAPEI-205


title: S85_DX-TB Subjects-140801_I162_FCC4T6AACXX_L1_RHUMjlxTAAFHRAAPEI-202


title: S85_day_7-TB Subjects-140801_I162_FCC4T6AACXX_L2_RHUMjlxTAAFIRAAPEI-203


title: S85_day_7-TB Subjects-140730_I284_FCC4N7JACXX_L2_RHUMjlxTAAFIRAAPEI-203


title: S85_DX-TB Subjects-140730_I284_FCC4N7JACXX_L1_RHUMjlxTAAFHRAAPEI-202


title: S84_week_24-TB Subjects-140801_I162_FCC4T6AACXX_L1_RHUMjlxTAAFGRAAPEI-201


title: S84_week_4-TB Subjects-140730_I284_FCC4N7JACXX_L1_RHUMjlxTAAFFRAAPEI-227


title: S84_DX-TB Subjects-140728_I175_FCC4RLLACXX_L7_RHUMjlxTAAFDRAAPEI-223


title: S84_DX-TB Subjects-140728_I175_FCC4RLLACXX_L8_RHUMjlxTAAFDRAAPEI-223


title: S84_day_7-TB Subjects-140730_I284_FCC4N7JACXX_L1_RHUMjlxTAAFERAAPEI-225


title: S83_week_4-TB Subjects-140728_I175_FCC4RLLACXX_L7_RHUMjlxTAAFBRAAPEI-221


title: S84_day_7-TB Subjects-140801_I162_FCC4T6AACXX_L1_RHUMjlxTAAFERAAPEI-225


title: S84_week_4-TB Subjects-140801_I162_FCC4T6AACXX_L1_RHUMjlxTAAFFRAAPEI-227


title: S84_week_24-TB Subjects-140730_I284_FCC4N7JACXX_L1_RHUMjlxTAAFGRAAPEI-201


title: S86_week_24-TB Subjects-140801_I162_FCC4T6AACXX_L3_RHUMjlxTAAFMRAAPEI-207


title: S83_week_24-TB Subjects-140728_I175_FCC4RLLACXX_L8_RHUMjlxTAAFCRAAPEI-222


title: S83_DX-TB Subjects-140728_I175_FCC4RLLACXX_L6_RHUMjlxTAAEZRAAPEI-219


title: S83_day_7-TB Subjects-140728_I175_FCC4RLLACXX_L8_RHUMjlxTAAFARAAPEI-220


title: S83_week_24-TB Subjects-140728_I175_FCC4RLLACXX_L7_RHUMjlxTAAFCRAAPEI-222


title: S81_week_4-TB Subjects-140728_I175_FCC4RLLACXX_L6_RHUMjlxTAAEXRAAPEI-216


title: S85_week_24-TB Subjects-140801_I162_FCC4T6AACXX_L2_RHUMjlxTAAFJRAAPEI-204


title: S81_week_24-TB Subjects-140728_I175_FCC4RLLACXX_L4_RHUMjlxTAAEYRAAPEI-218


title: S81_week_4-TB Subjects-140728_I175_FCC4RLLACXX_L4_RHUMjlxTAAEXRAAPEI-216


title: S81_DX-TB Subjects-140728_I175_FCC4RLLACXX_L3_RHUMjlxTAAEVRAAPEI-214


title: S83_week_4-TB Subjects-140728_I175_FCC4RLLACXX_L8_RHUMjlxTAAFBRAAPEI-221


title: S81_week_24-TB Subjects-140728_I175_FCC4RLLACXX_L6_RHUMjlxTAAEYRAAPEI-218


title: S83_DX-TB Subjects-140728_I175_FCC4RLLACXX_L4_RHUMjlxTAAEZRAAPEI-219


title: S81_DX-TB Subjects-140728_I175_FCC4RLLACXX_L2_RHUMjlxTAAEVRAAPEI-214


title: S81_day_7-TB Subjects-140728_I175_FCC4RLLACXX_L6_RHUMjlxTAAEWRAAPEI-215


title: S81_day_7-TB Subjects-140728_I175_FCC4RLLACXX_L4_RHUMjlxTAAEWRAAPEI-215


title: S80_week_4-TB Subjects-140728_I175_FCC4RLLACXX_L3_RHUMjlxTAAETRAAPEI-212

value: Unevaluable


title: S83_day_7-TB Subjects-140728_I175_FCC4RLLACXX_L7_RHUMjlxTAAFARAAPEI-220


title: S80_week_4-TB Subjects-140728_I175_FCC4RLLACXX_L2_RHUMjlxTAAETRAAPEI-212


title: S80_week_24-TB Subjects-140728_I175_FCC4RLLACXX_L3_RHUMjlxTAAEURAAPEI-213


title: S80_DX-TB Subjects-140808_I269_FCC4MTUACXX_L1_RHUMjlxTAAERRAAPEI-210


title: S80_DX-TB Subjects-140808_I269_FCC4MG0ACXX_L8_RHUMjlxTAAERRAAPEI-210


title: S80_day_7-TB Subjects-140728_I175_FCC4RLLACXX_L3_RHUMjlxTAAESRAAPEI-211


title: S80_day_7-TB Subjects-140728_I175_FCC4RLLACXX_L2_RHUMjlxTAAESRAAPEI-211


title: S7_week_4-TB Subjects-140724_I269_FCC4N6KACXX_L8_RHUMjlxTAAALRAAPEI-221


title: S80_week_24-TB Subjects-140728_I175_FCC4RLLACXX_L2_RHUMjlxTAAEURAAPEI-213


title: S7_DX-TB Subjects-140724_I269_FCC4N6KACXX_L8_RHUMjlxTAAAJRAAPEI-219


title: S7_week_24-TB Subjects-140724_I269_FCC4N24ACXX_L3_RHUMjlxTAAAMRAAPEI-222


title: S7_day_7-TB Subjects-140724_I269_FCC4N6KACXX_L8_RHUMjlxTAAAKRAAPEI-220


title: S7_day_7-TB Subjects-140724_I269_FCC4N24ACXX_L3_RHUMjlxTAAAKRAAPEI-220


title: S78_DX-TB Subjects-140728_I175_FCC4MJ2ACXX_L7_RHUMjlxTAAENRAAPEI-206


title: S7_DX-TB Subjects-140724_I269_FCC4N24ACXX_L3_RHUMjlxTAAAJRAAPEI-219


title: S78_day_7-TB Subjects-140808_I269_FCC4MG0ACXX_L8_RHUMjlxTAAEORAAPEI-207


title: S78_week_4-TB Subjects-140808_I269_FCC4MG0ACXX_L8_RHUMjlxTAAEPRAAPEI-208


title: S77_week_4-TB Subjects-140728_I175_FCC4MJ2ACXX_L6_RHUMjlxTAAELRAAPEI-204


title: S78_week_24-TB Subjects-140808_I269_FCC4MTUACXX_L1_RHUMjlxTAAEQRAAPEI-209


title: S77_week_24-TB Subjects-140728_I175_FCC4MJ2ACXX_L7_RHUMjlxTAAEMRAAPEI-205


title: S7_week_4-TB Subjects-140724_I269_FCC4N24ACXX_L3_RHUMjlxTAAALRAAPEI-221


title: S77_DX-TB Subjects-140728_I175_FCC4MJ2ACXX_L3_RHUMjlxTAAEJRAAPEI-202


title: S77_day_7-TB Subjects-140728_I175_FCC4MJ2ACXX_L7_RHUMjlxTAAEKRAAPEI-203


title: S78_week_24-TB Subjects-140808_I269_FCC4MG0ACXX_L8_RHUMjlxTAAEQRAAPEI-209


title: S77_day_7-TB Subjects-140728_I175_FCC4MJ2ACXX_L6_RHUMjlxTAAEKRAAPEI-203


title: S78_DX-TB Subjects-140728_I175_FCC4MJ2ACXX_L6_RHUMjlxTAAENRAAPEI-206


title: S77_week_24-TB Subjects-140728_I175_FCC4MJ2ACXX_L6_RHUMjlxTAAEMRAAPEI-205


title: S78_day_7-TB Subjects-140808_I269_FCC4MTUACXX_L1_RHUMjlxTAAEORAAPEI-207


title: S76_week_4-TB Subjects-140728_I175_FCC4MJ2ACXX_L3_RHUMjlxTAAEHRAAPEI-227


title: S76_week_24-TB Subjects-140728_I175_FCC4MJ2ACXX_L4_RHUMjlxTAAEIRAAPEI-201


title: S7_week_24-TB Subjects-140724_I269_FCC4N6KACXX_L8_RHUMjlxTAAAMRAAPEI-222


title: S76_DX-TB Subjects-140728_I175_FCC4MJ2ACXX_L1_RHUMjlxTAAEFRAAPEI-223


title: S76_day_7-TB Subjects-140728_I175_FCC4MJ2ACXX_L3_RHUMjlxTAAEGRAAPEI-225


title: S76_day_7-TB Subjects-140728_I175_FCC4MJ2ACXX_L4_RHUMjlxTAAEGRAAPEI-225


title: S73_week_4-TB Subjects-140728_I175_FCC4MJ2ACXX_L2_RHUMjlxTAAEDRAAPEI-221

value: Possible Cure


title: S73_week_4-TB Subjects-140728_I175_FCC4MJ2ACXX_L1_RHUMjlxTAAEDRAAPEI-221


title: S73_week_24-TB Subjects-140728_I175_FCC4MJ2ACXX_L1_RHUMjlxTAAEERAAPEI-222


title: S73_week_24-TB Subjects-140728_I175_FCC4MJ2ACXX_L2_RHUMjlxTAAEERAAPEI-222


title: S73_DX-TB Subjects-140727_I266_FCC4MHMACXX_L8_RHUMjlxTAAEBRAAPEI-219


title: S77_DX-TB Subjects-140728_I175_FCC4MJ2ACXX_L4_RHUMjlxTAAEJRAAPEI-202


title: S73_DX-TB Subjects-140727_I266_FCC4MHMACXX_L7_RHUMjlxTAAEBRAAPEI-219


title: S73_day_7-TB Subjects-140728_I175_FCC4MJ2ACXX_L2_RHUMjlxTAAECRAAPEI-220


title: S73_day_7-TB Subjects-140728_I175_FCC4MJ2ACXX_L1_RHUMjlxTAAECRAAPEI-220


title: S72_week_4-TB Subjects-140727_I266_FCC4MHMACXX_L8_RHUMjlxTAADZRAAPEI-216


title: S78_week_4-TB Subjects-140808_I269_FCC4MTUACXX_L1_RHUMjlxTAAEPRAAPEI-208


title: S72_week_24-TB Subjects-140727_I266_FCC4MHMACXX_L8_RHUMjlxTAAEARAAPEI-218


title: S72_week_24-TB Subjects-140727_I266_FCC4MHMACXX_L7_RHUMjlxTAAEARAAPEI-218


title: S72_day_7-TB Subjects-140727_I266_FCC4MHMACXX_L7_RHUMjlxTAADYRAAPEI-215


title: S72_day_7-TB Subjects-140727_I266_FCC4MHMACXX_L8_RHUMjlxTAADYRAAPEI-215


title: S71_week_4-TB Subjects-140727_I266_FCC4MHMACXX_L4_RHUMjlxTAADWRAAPEI-213


title: S71_week_24-TB Subjects-140727_I266_FCC4MHMACXX_L4_RHUMjlxTAADXRAAPEI-214


title: S76_week_24-TB Subjects-140728_I175_FCC4MJ2ACXX_L3_RHUMjlxTAAEIRAAPEI-201


title: S72_week_4-TB Subjects-140727_I266_FCC4MHMACXX_L7_RHUMjlxTAADZRAAPEI-216


title: S71_week_24-TB Subjects-140727_I266_FCC4MHMACXX_L6_RHUMjlxTAADXRAAPEI-214


title: S77_week_4-TB Subjects-140728_I175_FCC4MJ2ACXX_L7_RHUMjlxTAAELRAAPEI-204


title: S76_DX-TB Subjects-140728_I175_FCC4MJ2ACXX_L2_RHUMjlxTAAEFRAAPEI-223


title: S71_DX-TB Subjects-140727_I266_FCC4MHMACXX_L4_RHUMjlxTAADURAAPEI-211


title: S71_DX-TB Subjects-140727_I266_FCC4MHMACXX_L6_RHUMjlxTAADURAAPEI-211


title: S76_week_4-TB Subjects-140728_I175_FCC4MJ2ACXX_L4_RHUMjlxTAAEHRAAPEI-227


title: S71_day_7-TB Subjects-140727_I266_FCC4MHMACXX_L6_RHUMjlxTAADVRAAPEI-212


title: S70_week_24-TB Subjects-140727_I266_FCC4MHMACXX_L2_RHUMjlxTAADTRAAPEI-210


title: S70_week_24-TB Subjects-140727_I266_FCC4MHMACXX_L3_RHUMjlxTAADTRAAPEI-210


title: S70_week_4-TB Subjects-140727_I266_FCC4MHMACXX_L2_RHUMjlxTAADSRAAPEI-209


title: S70_DX-TB Subjects-140727_I266_FCC4MHMACXX_L3_RHUMjlxTAADQRAAPEI-207


title: S70_DX-TB Subjects-140727_I266_FCC4MHMACXX_L2_RHUMjlxTAADQRAAPEI-207


title: S70_week_4-TB Subjects-140727_I266_FCC4MHMACXX_L3_RHUMjlxTAADSRAAPEI-209


title: S70_day_7-TB Subjects-140727_I266_FCC4MHMACXX_L3_RHUMjlxTAADRRAAPEI-208


title: S5_week_4-TB Subjects-140711_I269_FCC4MBUACXX_L7_RHUMjlxTAAAHRAAPEI-216


title: S70_day_7-TB Subjects-140727_I266_FCC4MHMACXX_L2_RHUMjlxTAADRRAAPEI-208


title: S54_week_4-TB Subjects-140728_I175_FCC4RLLACXX_L1_RHUMjlxTAADORAAPEI-205


title: S5_week_24-TB Subjects-140724_I269_FCC4N6KACXX_L7_RHUMjlxTAAAIRAAPEI-218


title: S5_week_24-TB Subjects-140724_I269_FCC4N24ACXX_L2_RHUMjlxTAAAIRAAPEI-218


title: S54_week_4-TB Subjects-140728_I175_FCC4MJ2ACXX_L8_RHUMjlxTAADORAAPEI-205


title: S5_week_4-TB Subjects-140711_I269_FCC4MBUACXX_L8_RHUMjlxTAAAHRAAPEI-216


title: S54_DX-TB Subjects-140728_I175_FCC4RLLACXX_L1_RHUMjlxTAADMRAAPEI-203


title: S54_week_24-TB Subjects-140728_I175_FCC4MJ2ACXX_L8_RHUMjlxTAADPRAAPEI-206


title: S54_week_24-TB Subjects-140728_I175_FCC4RLLACXX_L1_RHUMjlxTAADPRAAPEI-206


title: S54_DX-TB Subjects-140728_I175_FCC4MJ2ACXX_L8_RHUMjlxTAADMRAAPEI-203


title: S54_day_7-TB Subjects-140728_I175_FCC4RLLACXX_L1_RHUMjlxTAADNRAAPEI-204


title: S53_week_4-TB Subjects-140726_I162_FCC4R77ACXX_L8_RHUMjlxTAADKRAAPEI-201


title: S53_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L8_RHUMjlxTAADLRAAPEI-202


title: S53_week_24-TB Subjects-140727_I266_FCC4MHMACXX_L1_RHUMjlxTAADLRAAPEI-202


title: S71_week_4-TB Subjects-140727_I266_FCC4MHMACXX_L6_RHUMjlxTAADWRAAPEI-213


title: S53_day_7-TB Subjects-140727_I266_FCC4MHMACXX_L1_RHUMjlxTAADJRAAPEI-227


title: S53_day_7-TB Subjects-140726_I162_FCC4R77ACXX_L8_RHUMjlxTAADJRAAPEI-227


title: S53_DX-TB Subjects-140726_I162_FCC4R77ACXX_L8_RHUMjlxTAADIRAAPEI-225


title: S53_week_4-TB Subjects-140727_I266_FCC4MHMACXX_L1_RHUMjlxTAADKRAAPEI-201


title: S54_day_7-TB Subjects-140728_I175_FCC4MJ2ACXX_L8_RHUMjlxTAADNRAAPEI-204


title: S52_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L6_RHUMjlxTAADHRAAPEI-223


title: S52_week_4-TB Subjects-140726_I162_FCC4R77ACXX_L6_RHUMjlxTAADGRAAPEI-222


title: S52_day_7-TB Subjects-140726_I162_FCC4R77ACXX_L7_RHUMjlxTAADFRAAPEI-221


title: S52_day_7-TB Subjects-140726_I162_FCC4R77ACXX_L6_RHUMjlxTAADFRAAPEI-221


title: S52_DX-TB Subjects-140812_I270_FCC4N2DACXX_L6_RHUMjlxTAADERBAPEI-220


title: S51_week_4-TB Subjects-140726_I162_FCC4R77ACXX_L4_RHUMjlxTAADCRAAPEI-218


title: S51_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L6_RHUMjlxTAADDRAAPEI-219


title: S51_DX-TB Subjects-140726_I162_FCC4R77ACXX_L3_RHUMjlxTAADARAAPEI-215


title: S51_DX-TB Subjects-140726_I162_FCC4R77ACXX_L4_RHUMjlxTAADARAAPEI-215


title: S51_week_4-TB Subjects-140726_I162_FCC4R77ACXX_L3_RHUMjlxTAADCRAAPEI-218


title: S51_day_7-TB Subjects-140726_I162_FCC4R77ACXX_L4_RHUMjlxTAADBRAAPEI-216


title: S52_DX-TB Subjects-140812_I270_FCC4N2DACXX_L7_RHUMjlxTAADERBAPEI-220


title: S53_DX-TB Subjects-140727_I266_FCC4MHMACXX_L1_RHUMjlxTAADIRAAPEI-225


title: S71_day_7-TB Subjects-140727_I266_FCC4MHMACXX_L4_RHUMjlxTAADVRAAPEI-212


title: S50_week_4-TB Subjects-140726_I162_FCC4R77ACXX_L2_RHUMjlxTAACYRAAPEI-213


title: S51_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L7_RHUMjlxTAADDRAAPEI-219


title: S51_day_7-TB Subjects-140726_I162_FCC4R77ACXX_L3_RHUMjlxTAADBRAAPEI-216


title: S50_week_4-TB Subjects-140726_I162_FCC4R77ACXX_L1_RHUMjlxTAACYRAAPEI-213


title: S50_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L4_RHUMjlxTAACZRAAPEI-214


title: S50_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L3_RHUMjlxTAACZRAAPEI-214


title: S50_DX-TB Subjects-140726_I162_FCC4R77ACXX_L2_RHUMjlxTAACWRAAPEI-211


title: S50_day_7-TB Subjects-140726_I162_FCC4R77ACXX_L2_RHUMjlxTAACXRAAPEI-212


title: S52_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L7_RHUMjlxTAADHRAAPEI-223


title: S52_week_4-TB Subjects-140726_I162_FCC4R77ACXX_L7_RHUMjlxTAADGRAAPEI-222


title: S50_day_7-TB Subjects-140726_I162_FCC4R77ACXX_L1_RHUMjlxTAACXRAAPEI-212


title: S4_week_24-TB Subjects-140711_I269_FCC4MBUACXX_L8_RHUMjlxTAAAGRAAPEI-215


title: S4_week_24-TB Subjects-140711_I269_FCC4MBUACXX_L7_RHUMjlxTAAAGRAAPEI-215


title: S4_week_4-TB Subjects-140711_I269_FCC4MBUACXX_L8_RHUMjlxTAAAFRAAPEI-214


title: S49_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L8_RHUMjlxTAACURAAPEI-209


title: S49_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L2_RHUMjlxTAACVRAAPEI-210


title: S49_DX-TB Subjects-140726_I162_FCC4NAWACXX_L7_RHUMjlxTAACSRAAPEI-207


title: S49_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L7_RHUMjlxTAACURAAPEI-209


title: S49_week_24-TB Subjects-140726_I162_FCC4R77ACXX_L1_RHUMjlxTAACVRAAPEI-210


title: S49_day_7-TB Subjects-140726_I162_FCC4NAWACXX_L8_RHUMjlxTAACTRAAPEI-208


title: S43_day_7-TB Subjects-140726_I162_FCC4NAWACXX_L6_RHUMjlxTAACQRAAPEI-205

value: Not Cured


title: S50_DX-TB Subjects-140726_I162_FCC4R77ACXX_L1_RHUMjlxTAACWRAAPEI-211


title: S43_day_7-TB Subjects-140726_I162_FCC4NAWACXX_L4_RHUMjlxTAACQRAAPEI-205


title: S43_DX-TB Subjects-140726_I162_FCC4NAWACXX_L4_RHUMjlxTAACPRAAPEI-204


title: S42_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L6_RHUMjlxTAACNRAAPEI-202


title: S42_week_24-TB Subjects-140726_I162_FCC4NAWACXX_L6_RHUMjlxTAACORAAPEI-203


title: S43_DX-TB Subjects-140726_I162_FCC4NAWACXX_L6_RHUMjlxTAACPRAAPEI-204


title: S42_DX-TB Subjects-140726_I162_FCC4NAWACXX_L3_RHUMjlxTAACLRAAPEI-227


title: S42_day_7-TB Subjects-140726_I162_FCC4NAWACXX_L3_RHUMjlxTAACMRAAPEI-201


title: S42_day_7-TB Subjects-140726_I162_FCC4NAWACXX_L2_RHUMjlxTAACMRAAPEI-201


title: S41_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L2_RHUMjlxTAACJRAAPEI-223


title: S42_DX-TB Subjects-140726_I162_FCC4NAWACXX_L2_RHUMjlxTAACLRAAPEI-227


title: S41_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L3_RHUMjlxTAACJRAAPEI-223


title: S4_week_4-TB Subjects-140711_I269_FCC4MBUACXX_L7_RHUMjlxTAAAFRAAPEI-214


title: S49_DX-TB Subjects-140726_I162_FCC4NAWACXX_L8_RHUMjlxTAACSRAAPEI-207


title: S49_day_7-TB Subjects-140726_I162_FCC4NAWACXX_L7_RHUMjlxTAACTRAAPEI-208


title: S43_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L8_RHUMjlxTAACRRAAPEI-206


title: S42_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L4_RHUMjlxTAACNRAAPEI-202


title: S42_week_24-TB Subjects-140726_I162_FCC4NAWACXX_L4_RHUMjlxTAACORAAPEI-203


title: S41_week_24-TB Subjects-140726_I162_FCC4NAWACXX_L3_RHUMjlxTAACKRAAPEI-225


title: S41_DX-TB Subjects-140726_I162_FCC4NAWACXX_L1_RHUMjlxTAACHRAAPEI-221


title: S41_day_7-TB Subjects-140726_I162_FCC4NAWACXX_L1_RHUMjlxTAACIRAAPEI-222


title: S41_week_24-TB Subjects-140726_I162_FCC4NAWACXX_L2_RHUMjlxTAACKRAAPEI-225


title: S3_week_4-TB Subjects-140711_I269_FCC4MBUACXX_L6_RHUMjlxTAAADRAAPEI-212


title: S3_week_24-TB Subjects-140711_I269_FCC4MBUACXX_L7_RHUMjlxTAAAERAAPEI-213


title: S3_week_4-TB Subjects-140711_I269_FCC4MBUACXX_L4_RHUMjlxTAAADRAAPEI-212


title: S35_week_24-TB Subjects-140726_I232_FCC4N2GACXX_L8_RHUMjlxTAACGRAAPEI-220


title: S3_week_24-TB Subjects-140711_I269_FCC4MBUACXX_L8_RHUMjlxTAAAERAAPEI-213


title: S35_week_4-TB Subjects-140726_I232_FCC4N2GACXX_L8_RHUMjlxTAACFRAAPEI-219


title: S35_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L1_RHUMjlxTAACFRAAPEI-219


title: S35_DX-TB Subjects-140726_I232_FCC4N2GACXX_L6_RHUMjlxTAACDRAAPEI-216


title: S35_week_24-TB Subjects-140726_I162_FCC4NAWACXX_L1_RHUMjlxTAACGRAAPEI-220


title: S35_day_7-TB Subjects-140726_I232_FCC4N2GACXX_L6_RHUMjlxTAACERAAPEI-218


title: S34_week_4-TB Subjects-140726_I232_FCC4N2GACXX_L7_RHUMjlxTAACBRAAPEI-214


title: S35_DX-TB Subjects-140726_I232_FCC4N2GACXX_L7_RHUMjlxTAACDRAAPEI-216


title: S34_week_4-TB Subjects-140726_I232_FCC4N2GACXX_L6_RHUMjlxTAACBRAAPEI-214


title: S34_week_24-TB Subjects-140726_I232_FCC4N2GACXX_L6_RHUMjlxTAACCRAAPEI-215


title: S34_DX-TB Subjects-140726_I232_FCC4N2GACXX_L3_RHUMjlxTAABZRAAPEI-212


title: S34_DX-TB Subjects-140726_I232_FCC4N2GACXX_L4_RHUMjlxTAABZRAAPEI-212


title: S41_day_7-TB Subjects-140726_I232_FCC4N2GACXX_L8_RHUMjlxTAACIRAAPEI-222


title: S34_week_24-TB Subjects-140726_I232_FCC4N2GACXX_L7_RHUMjlxTAACCRAAPEI-215


title: S30_week_4-TB Subjects-140726_I232_FCC4N2GACXX_L4_RHUMjlxTAABXRAAPEI-210


title: S34_day_7-TB Subjects-140726_I232_FCC4N2GACXX_L3_RHUMjlxTAACARAAPEI-213


title: S34_day_7-TB Subjects-140726_I232_FCC4N2GACXX_L4_RHUMjlxTAACARAAPEI-213


title: S35_day_7-TB Subjects-140726_I232_FCC4N2GACXX_L7_RHUMjlxTAACERAAPEI-218


title: S30_week_24-TB Subjects-140726_I232_FCC4N2GACXX_L4_RHUMjlxTAABYRAAPEI-211


title: S30_week_24-TB Subjects-140726_I232_FCC4N2GACXX_L3_RHUMjlxTAABYRAAPEI-211


title: S30_week_4-TB Subjects-140726_I232_FCC4N2GACXX_L3_RHUMjlxTAABXRAAPEI-210


title: S2_week_4-TB Subjects-140711_I269_FCC4MBUACXX_L4_RHUMjlxTAAABRAAPEI-210


title: S30_day_7-TB Subjects-140724_I269_FCC4N6KACXX_L6_RHUMjlxTAABWRAAPEI-209


title: S2_week_24-TB Subjects-140711_I269_FCC4MBUACXX_L6_RHUMjlxTAAACRAAPEI-211


title: S30_DX-TB Subjects-140724_I269_FCC4N6KACXX_L6_RHUMjlxTAABVRAAPEI-208


title: S2_week_4-TB Subjects-140711_I269_FCC4MBUACXX_L6_RHUMjlxTAAABRAAPEI-210


title: S30_day_7-TB Subjects-140726_I232_FCC4N2GACXX_L2_RHUMjlxTAABWRAAPEI-209


title: S2_week_24-TB Subjects-140711_I269_FCC4MBUACXX_L4_RHUMjlxTAAACRAAPEI-211


title: S30_DX-TB Subjects-140726_I232_FCC4N2GACXX_L2_RHUMjlxTAABVRAAPEI-208


title: S29_day_7-TB Subjects-140726_I232_FCC4N2GACXX_L2_RHUMjlxTAABTRAAPEI-206


title: S29_DX-TB Subjects-140726_I232_FCC4N2GACXX_L1_RHUMjlxTAABSRAAPEI-205


title: S29_week_4-TB Subjects-140726_I232_FCC4N2GACXX_L2_RHUMjlxTAABURAAPEI-207


title: S29_DX-TB Subjects-140724_I269_FCC4N6KACXX_L4_RHUMjlxTAABSRAAPEI-205


title: S29_day_7-TB Subjects-140724_I269_FCC4N6KACXX_L6_RHUMjlxTAABTRAAPEI-206


title: S27_week_4-TB Subjects-140726_I232_FCC4N2GACXX_L1_RHUMjlxTAABQRAAPEI-203


title: S29_week_4-TB Subjects-140724_I269_FCC4N6KACXX_L6_RHUMjlxTAABURAAPEI-207


title: S27_week_4-TB Subjects-140724_I269_FCC4N6KACXX_L4_RHUMjlxTAABQRAAPEI-203


title: S27_DX-TB Subjects-140724_I269_FCC4N6KACXX_L3_RHUMjlxTAABORAAPEI-201


title: S27_day_7-TB Subjects-140726_I232_FCC4N2GACXX_L1_RHUMjlxTAABPRAAPEI-202


title: S27_week_24-TB Subjects-140726_I232_FCC4N2GACXX_L1_RHUMjlxTAABRRAAPEI-204


title: S27_week_24-TB Subjects-140724_I269_FCC4N6KACXX_L4_RHUMjlxTAABRRAAPEI-204


title: S27_DX-TB Subjects-140726_I232_FCC4NA4ACXX_L8_RHUMjlxTAABORAAPEI-201


title: S24_week_4-TB Subjects-140724_I269_FCC4N6KACXX_L3_RHUMjlxTAABMRAAPEI-225


title: S24_week_4-TB Subjects-140726_I232_FCC4NA4ACXX_L8_RHUMjlxTAABMRAAPEI-225


title: S27_day_7-TB Subjects-140724_I269_FCC4N6KACXX_L4_RHUMjlxTAABPRAAPEI-202


title: S24_week_24-TB Subjects-140724_I269_FCC4N6KACXX_L3_RHUMjlxTAABNRAAPEI-227


title: S22_week_24-TB Subjects-140726_I232_FCC4NA4ACXX_L7_RHUMjlxTAABJRAAPEI-221


title: S22_week_4-TB Subjects-140724_I269_FCC4N6KACXX_L1_RHUMjlxTAABIRAAPEI-220


title: S22_week_4-TB Subjects-140726_I232_FCC4NA4ACXX_L6_RHUMjlxTAABIRAAPEI-220


title: S22_DX-TB Subjects-140726_I232_FCC4NA4ACXX_L6_RHUMjlxTAABGRAAPEI-218


title: S24_week_24-TB Subjects-140726_I232_FCC4NA4ACXX_L8_RHUMjlxTAABNRAAPEI-227


title: S24_day_7-TB Subjects-140724_I269_FCC4N6KACXX_L3_RHUMjlxTAABLRAAPEI-223


title: S24_DX-TB Subjects-140724_I269_FCC4N6KACXX_L2_RHUMjlxTAABKRAAPEI-222


title: S41_DX-TB Subjects-140726_I232_FCC4N2GACXX_L8_RHUMjlxTAACHRAAPEI-221


title: S22_DX-TB Subjects-140724_I269_FCC4N6KACXX_L1_RHUMjlxTAABGRAAPEI-218


title: S22_week_24-TB Subjects-140724_I269_FCC4N6KACXX_L2_RHUMjlxTAABJRAAPEI-221


title: S22_day_7-TB Subjects-140726_I232_FCC4NA4ACXX_L7_RHUMjlxTAABHRAAPEI-219


title: S22_day_7-TB Subjects-140724_I269_FCC4N6KACXX_L2_RHUMjlxTAABHRAAPEI-219


title: S221_DX-NA-140815_I272_FCC4MUGACXX_L4_RHUMjlxTAARJRAAPEI-204


title: S220_DX-NA-140815_I272_FCC4MUGACXX_L4_RHUMjlxTAARIRAAPEI-203


title: S221_DX-NA-140815_I272_FCC4MUGACXX_L3_RHUMjlxTAARJRAAPEI-204


title: S222_DX-NA-140815_I272_FCC4MUGACXX_L4_RHUMjlxTAARKRAAPEI-205


title: S21_week_4-TB Subjects-140724_I269_FCC4N6KACXX_L1_RHUMjlxTAABERAAPEI-215


title: S21_week_4-TB Subjects-140726_I232_FCC4NA4ACXX_L6_RHUMjlxTAABERAAPEI-215


title: S220_DX-NA-140815_I272_FCC4MUGACXX_L3_RHUMjlxTAARIRAAPEI-203


title: S21_week_24-TB Subjects-140724_I269_FCC4N6KACXX_L2_RHUMjlxTAABFRAAPEI-216


title: S21_DX-TB Subjects-140726_I232_FCC4NA4ACXX_L6_RHUMjlxTAABDRAAPEI-214


title: S21_week_24-TB Subjects-140726_I232_FCC4NA4ACXX_L7_RHUMjlxTAABFRAAPEI-216


title: S21_DX-TB Subjects-140724_I269_FCC4N6KACXX_L1_RHUMjlxTAABDRAAPEI-214


title: S219_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L4_RHUMjlxTAARHRAAPEI-202

value: Healthy Controls


title: S24_DX-TB Subjects-140726_I232_FCC4NA4ACXX_L7_RHUMjlxTAABKRAAPEI-222


title: S24_day_7-TB Subjects-140726_I232_FCC4NA4ACXX_L8_RHUMjlxTAABLRAAPEI-223


title: S219_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L3_RHUMjlxTAARHRAAPEI-202


title: S218_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L2_RHUMjlxTAARGRAAPEI-201


title: S217_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L2_RHUMjlxTAARFRAAPEI-227


title: S218_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L1_RHUMjlxTAARGRAAPEI-201


title: S214_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L1_RHUMjlxTAARDRAAPEI-223


title: S214_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L2_RHUMjlxTAARDRAAPEI-223


title: S222_DX-NA-140815_I272_FCC4MUGACXX_L3_RHUMjlxTAARKRAAPEI-205


title: S217_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L1_RHUMjlxTAARFRAAPEI-227


title: S216_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L1_RHUMjlxTAARERAAPEI-225


title: S213_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L8_RHUMjlxTAARCRAAPEI-222


title: S213_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L7_RHUMjlxTAARCRAAPEI-222


title: S211-Healthy Controls-140817_I162_FCC4MT4ACXX_L8_RHUMjlxTAARARAAPEI-220


title: S211-Healthy Controls-140817_I162_FCC4MT4ACXX_L7_RHUMjlxTAARARAAPEI-220


title: S210_week_8-Healthy Controls-140817_I162_FCC4MT4ACXX_L3_RHUMjlxTAAQORAAPEI-207


title: S210_week_4-Healthy Controls-140817_I162_FCC4MT4ACXX_L3_RHUMjlxTAAQNRAAPEI-206


title: S212_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L8_RHUMjlxTAARBRAAPEI-221


title: S212_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L7_RHUMjlxTAARBRAAPEI-221


title: S210_DX-Healthy Controls-140812_I232_FCC4MRBACXX_L8_RHUMjlxTAAQLRAAPEI-204


title: S20_week_24-TB Subjects-140726_I232_FCC4NA4ACXX_L4_RHUMjlxTAABCRAAPEI-213


title: S20_week_4-TB Subjects-140724_I269_FCC4N24ACXX_L8_RHUMjlxTAABBRAAPEI-212


title: S210_day_7-Healthy Controls-140817_I162_FCC4MT4ACXX_L1_RHUMjlxTAAQMRAAPEI-205


title: S210_week_4-Healthy Controls-140817_I162_FCC4MT4ACXX_L2_RHUMjlxTAAQNRAAPEI-206


title: S210_day_7-Healthy Controls-140812_I232_FCC4MRBACXX_L8_RHUMjlxTAAQMRAAPEI-205


title: S20_week_24-TB Subjects-140724_I269_FCC4N24ACXX_L8_RHUMjlxTAABCRAAPEI-213


title: S20_DX-TB Subjects-140726_I232_FCC4NA4ACXX_L4_RHUMjlxTAAAZRAAPEI-210


title: S20_DX-TB Subjects-140724_I269_FCC4N24ACXX_L8_RHUMjlxTAAAZRAAPEI-210


title: S216_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L2_RHUMjlxTAARERAAPEI-225


title: S20_day_7-TB Subjects-140724_I269_FCC4N24ACXX_L8_RHUMjlxTAABARAAPEI-211


title: S209_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L8_RHUMjlxTAAQKRAAPEI-203


title: S20_day_7-TB Subjects-140726_I232_FCC4NA4ACXX_L4_RHUMjlxTAABARAAPEI-211


title: S208_week_8-Healthy Controls-140812_I232_FCC4MRBACXX_L7_RHUMjlxTAAQIRAAPEI-201


title: S210_week_8-Healthy Controls-140817_I162_FCC4MT4ACXX_L2_RHUMjlxTAAQORAAPEI-207


title: S209_DX-Healthy Controls-140812_I232_FCC4MRBACXX_L8_RHUMjlxTAAQJRAAPEI-202


title: S209_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L1_RHUMjlxTAAQJRAAPEI-202


title: S208_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L7_RHUMjlxTAAQHRAAPEI-227


title: S208_week_8-Healthy Controls-140812_I232_FCC4MRBACXX_L6_RHUMjlxTAAQIRAAPEI-201


title: S208_DX-Healthy Controls-140812_I232_FCC4MRBACXX_L6_RHUMjlxTAAQGRAAPEI-225


title: S210_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L1_RHUMjlxTAAQLRAAPEI-204


title: S208_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L6_RHUMjlxTAAQHRAAPEI-227


title: S207_week_8-Healthy Controls-140812_I232_FCC4MRBACXX_L7_RHUMjlxTAAQFRAAPEI-223


title: S20_week_4-TB Subjects-140726_I232_FCC4NA4ACXX_L4_RHUMjlxTAABBRAAPEI-212


title: S208_DX-Healthy Controls-140812_I232_FCC4MRBACXX_L7_RHUMjlxTAAQGRAAPEI-225


title: S207_week_8-Healthy Controls-140812_I232_FCC4MRBACXX_L6_RHUMjlxTAAQFRAAPEI-223


title: S207_DX-Healthy Controls-140812_I232_FCC4MRBACXX_L4_RHUMjlxTAAQCRAAPEI-220


title: S207_day_7-Healthy Controls-140812_I232_FCC4MRBACXX_L4_RHUMjlxTAAQDRAAPEI-221


title: S207_day_7-Healthy Controls-140812_I232_FCC4MRBACXX_L3_RHUMjlxTAAQDRAAPEI-221


title: S206_week_8-Healthy Controls-140812_I232_FCC4MRBACXX_L4_RHUMjlxTAAQBRAAPEI-219


title: S206_week_8-Healthy Controls-140812_I232_FCC4MRBACXX_L3_RHUMjlxTAAQBRAAPEI-219


title: S206_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L2_RHUMjlxTAAQARAAPEI-218


title: S207_DX-Healthy Controls-140812_I232_FCC4MRBACXX_L3_RHUMjlxTAAQCRAAPEI-220


title: S206_DX-Healthy Controls-140812_I232_FCC4MRBACXX_L2_RHUMjlxTAAPZRAAPEI-216


title: S206_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L1_RHUMjlxTAAQARAAPEI-218


title: S209_week_4-Healthy Controls-140817_I162_FCC4MT4ACXX_L1_RHUMjlxTAAQKRAAPEI-203


title: S206_DX-Healthy Controls-140812_I232_FCC4MRBACXX_L1_RHUMjlxTAAPZRAAPEI-216


title: S205_week_8-Healthy Controls-140812_I232_FCC4MRBACXX_L1_RHUMjlxTAAPYRAAPEI-215


title: S205_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L2_RHUMjlxTAAPXRAAPEI-214


title: S207_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L3_RHUMjlxTAAQERAAPEI-222


title: S205_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L1_RHUMjlxTAAPXRAAPEI-214


title: S207_week_4-Healthy Controls-140812_I232_FCC4MRBACXX_L4_RHUMjlxTAAQERAAPEI-222


title: S205_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L7_RHUMjlxTAAPVRAAPEI-212


title: S205_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L8_RHUMjlxTAAPVRAAPEI-212


title: S205_day_7-Healthy Controls-140815_I272_FCC4MUGACXX_L8_RHUMjlxTAAPWRAAPEI-213


title: S205_day_7-Healthy Controls-140815_I272_FCC4MUGACXX_L7_RHUMjlxTAAPWRAAPEI-213


title: S1_week_24-TB Subjects-140711_I269_FCC4MBUACXX_L6_RHUMjlxTAAAARAAPEI-209


title: S202_DX-MTP Controls-140817_I162_FCC4MT4ACXX_L7_RHUMjlxTAAQZRAAPEI-219

value: MTP Controls


title: S200_DX-MTP Controls-140817_I162_FCC4MT4ACXX_L6_RHUMjlxTAAQYRAAPEI-218


title: S1_week_24-TB Subjects-140711_I269_FCC4MBUACXX_L4_RHUMjlxTAAAARAAPEI-209


title: S202_DX-MTP Controls-140817_I162_FCC4MT4ACXX_L8_RHUMjlxTAAQZRAAPEI-219


title: S19_week_4-TB Subjects-140724_I269_FCC4N24ACXX_L7_RHUMjlxTAAAXRAAPEI-208


title: S19_DX-TB Subjects-140726_I232_FCC4NA4ACXX_L3_RHUMjlxTAAAVRAAPEI-206


title: S19_week_24-TB Subjects-140724_I269_FCC4N24ACXX_L7_RHUMjlxTAAAYRAAPEI-209


title: S19_day_7-TB Subjects-140726_I232_FCC4NA4ACXX_L2_RHUMjlxTAAAWRAAPEI-207


title: S19_day_7-TB Subjects-140724_I269_FCC4N24ACXX_L6_RHUMjlxTAAAWRAAPEI-207


title: S199_DX-MTP Controls-140817_I162_FCC4MT4ACXX_L6_RHUMjlxTAAQXRAAPEI-216


title: S19_week_24-TB Subjects-140726_I232_FCC4NA4ACXX_L3_RHUMjlxTAAAYRAAPEI-209


title: S19_DX-TB Subjects-140724_I269_FCC4N24ACXX_L7_RHUMjlxTAAAVRAAPEI-206


title: S199_DX-MTP Controls-140817_I162_FCC4MT4ACXX_L4_RHUMjlxTAAQXRAAPEI-216


title: S198_DX-MTP Controls-140817_I162_FCC4MT4ACXX_L6_RHUMjlxTAAQWRAAPEI-215


title: S198_DX-MTP Controls-140817_I162_FCC4MT4ACXX_L4_RHUMjlxTAAQWRAAPEI-215


title: S205_week_8-Healthy Controls-140812_I232_FCC4MRBACXX_L2_RHUMjlxTAAPYRAAPEI-215


title: S197_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L6_RHUMjlxTAAQVRAAPEI-214


title: S197_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L4_RHUMjlxTAAQVRAAPEI-214


title: S200_DX-MTP Controls-140817_I162_FCC4MT4ACXX_L4_RHUMjlxTAAQYRAAPEI-218


title: S195_DX-Healthy Controls-140809_I266_FCC4N1RACXX_L5_RHUMjlxTAAQURAAPEI-213


title: S195_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L6_RHUMjlxTAAQURAAPEI-213


title: S195_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L5_RHUMjlxTAAQURAAPEI-213


title: S195_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L5_RHUMjlxTAAQURAAPEI-213


title: S194_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L5_RHUMjlxTAAQTRAAPEI-212


title: S194_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L6_RHUMjlxTAAQTRAAPEI-212


title: S190_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L8_RHUMjlxTAAPERAAPEI-220

value: Lung Dx Controls


title: S190_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L8_RHUMjlxTAAPDRAAPEI-219


title: S190_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L7_RHUMjlxTAAPERAAPEI-220


title: S194_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L5_RHUMjlxTAAQTRAAPEI-212


title: S194_DX-Healthy Controls-140809_I266_FCC4N1RACXX_L5_RHUMjlxTAAQTRAAPEI-212


title: S188_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L6_RHUMjlxTAAPCRAAPEI-218


title: S188_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L4_RHUMjlxTAAPBRAAPEI-216


title: S190_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L7_RHUMjlxTAAPDRAAPEI-219


title: S19_week_4-TB Subjects-140726_I232_FCC4NA4ACXX_L3_RHUMjlxTAAAXRAAPEI-208


title: S186_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L4_RHUMjlxTAAPARAAPEI-215


title: S186_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L4_RHUMjlxTAAOZRAAPEI-214


title: S186_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L6_RHUMjlxTAAOZRAAPEI-214


title: S184_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L2_RHUMjlxTAAOYRAAPEI-213


title: S184_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L3_RHUMjlxTAAOYRAAPEI-213


title: S186_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L6_RHUMjlxTAAPARAAPEI-215


title: S188_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L6_RHUMjlxTAAPBRAAPEI-216


title: S184_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L3_RHUMjlxTAAOXRAAPEI-212


title: S188_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L4_RHUMjlxTAAPCRAAPEI-218


title: S182_week_8-MTP Controls-140815_I272_FCC4MUGACXX_L8_RHUMjlxTAAPURAAPEI-211


title: S184_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L2_RHUMjlxTAAOXRAAPEI-212


title: S182_week_8-MTP Controls-140815_I272_FCC4MUGACXX_L7_RHUMjlxTAAPURAAPEI-211


title: S182_week_4-MTP Controls-140815_I272_FCC4MUGACXX_L8_RHUMjlxTAAPTRAAPEI-210


title: S182_week_4-MTP Controls-140815_I272_FCC4MUGACXX_L7_RHUMjlxTAAPTRAAPEI-210


title: S182_DX-MTP Controls-140812_I270_FCC4N2DACXX_L7_RHUMjlxTAAPRRAAPEI-208


title: S43_week_4-TB Subjects-140726_I162_FCC4NAWACXX_L7_RHUMjlxTAACRRAAPEI-206


title: S182_day_7-MTP Controls-140815_I175_FCC4MVKACXX_L8_RHUMjlxTAAPSRAAPEI-209


title: S182_DX-MTP Controls-140812_I270_FCC4N2DACXX_L6_RHUMjlxTAAPRRAAPEI-208


title: S181_week_8-MTP Controls-140812_I270_FCC4N2DACXX_L7_RHUMjlxTAAPQRAAPEI-207


title: S182_day_7-MTP Controls-140815_I175_FCC4MVKACXX_L7_RHUMjlxTAAPSRAAPEI-209


title: S181_week_8-MTP Controls-140812_I270_FCC4N2DACXX_L6_RHUMjlxTAAPQRAAPEI-207


title: S181_day_7-MTP Controls-140812_I270_FCC4N2DACXX_L4_RHUMjlxTAAPORAAPEI-205


title: S181_week_4-MTP Controls-140812_I270_FCC4N2DACXX_L6_RHUMjlxTAAPPRAAPEI-206


title: S181_week_4-MTP Controls-140812_I270_FCC4N2DACXX_L7_RHUMjlxTAAPPRAAPEI-206


title: S181_day_7-MTP Controls-140812_I270_FCC4N2DACXX_L3_RHUMjlxTAAPORAAPEI-205


title: S180_DX-MTP Controls-140812_I270_FCC4N2DACXX_L1_RHUMjlxTAAPJRAAPEI-227


title: S180_day_7-MTP Controls-140812_I270_FCC4N2DACXX_L2_RHUMjlxTAAPKRAAPEI-201


title: S180_week_4-MTP Controls-140812_I270_FCC4N2DACXX_L3_RHUMjlxTAAPLRAAPEI-202


title: S180_week_8-MTP Controls-140812_I270_FCC4N2DACXX_L4_RHUMjlxTAAPMRAAPEI-203


title: S180_DX-MTP Controls-140812_I270_FCC4N2DACXX_L2_RHUMjlxTAAPJRAAPEI-227


title: S180_week_8-MTP Controls-140812_I270_FCC4N2DACXX_L3_RHUMjlxTAAPMRAAPEI-203


title: S179_week_4-MTP Controls-140812_I270_FCC4N2DACXX_L1_RHUMjlxTAAPHRAAPEI-223


title: S179_DX-MTP Controls-140812_I270_FCC4MR9ACXX_L8_RHUMjlxTAAPFRAAPEI-221


title: S180_day_7-MTP Controls-140812_I270_FCC4N2DACXX_L1_RHUMjlxTAAPKRAAPEI-201


title: S180_week_4-MTP Controls-140812_I270_FCC4N2DACXX_L4_RHUMjlxTAAPLRAAPEI-202


title: S179_week_4-MTP Controls-140812_I270_FCC4N2DACXX_L2_RHUMjlxTAAPHRAAPEI-223


title: S179_week_8-MTP Controls-140812_I270_FCC4N2DACXX_L2_RHUMjlxTAAPIRAAPEI-225


title: S179_DX-MTP Controls-140812_I270_FCC4MR9ACXX_L7_RHUMjlxTAAPFRAAPEI-221


title: S179_day_7-MTP Controls-140812_I270_FCC4MR9ACXX_L8_RHUMjlxTAAPGRAAPEI-222


title: S179_week_8-MTP Controls-140812_I270_FCC4N2DACXX_L1_RHUMjlxTAAPIRAAPEI-225


title: S179_day_7-MTP Controls-140812_I270_FCC4MR9ACXX_L7_RHUMjlxTAAPGRAAPEI-222


title: S178_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L2_RHUMjlxTAAOWRAAPEI-211


title: S181_DX-MTP Controls-140812_I270_FCC4N2DACXX_L4_RHUMjlxTAAPNRAAPEI-204


title: S181_DX-MTP Controls-140812_I270_FCC4N2DACXX_L3_RHUMjlxTAAPNRAAPEI-204


title: S178_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L3_RHUMjlxTAAOWRAAPEI-211


title: S177_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L1_RHUMjlxTAAOURAAPEI-209


title: S178_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L2_RHUMjlxTAAOVRAAPEI-210


title: S177_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L1_RHUMjlxTAAOTRAAPEI-208


title: S177_week_4-Lung Dx Controls-140809_I266_FCC4MRWACXX_L8_RHUMjlxTAAOURAAPEI-209


title: S173_week_4-Lung Dx Controls-140809_I266_FCC4MRWACXX_L8_RHUMjlxTAAOSRAAPEI-207


title: S177_DX-Lung Dx Controls-140809_I266_FCC4MRWACXX_L8_RHUMjlxTAAOTRAAPEI-208


title: S178_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L3_RHUMjlxTAAOVRAAPEI-210


title: S173_week_4-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L1_RHUMjlxTAAOSRAAPEI-207


title: S173_DX-Lung Dx Controls-140812_I270_FCC4MR9ACXX_L1_RHUMjlxTAAORRAAPEI-206


title: S173_DX-Lung Dx Controls-140809_I266_FCC4MRWACXX_L8_RHUMjlxTAAORRAAPEI-206


title: S172_DX-Lung Dx Controls-140809_I266_FCC4MRWACXX_L6_RHUMjlxTAAOPRAAPEI-204


title: S172_week_4-Lung Dx Controls-140809_I266_FCC4MRWACXX_L7_RHUMjlxTAAOQRAAPEI-205


title: S172_week_4-Lung Dx Controls-140809_I266_FCC4MRWACXX_L6_RHUMjlxTAAOQRAAPEI-205


title: S172_DX-Lung Dx Controls-140809_I266_FCC4MRWACXX_L7_RHUMjlxTAAOPRAAPEI-204


title: S171_DX-TB Subjects-140809_I266_FCC4MRWACXX_L4_RHUMjlxTAAOJRAAPEI-223


title: S171_week_24-TB Subjects-140809_I266_FCC4MRWACXX_L4_RHUMjlxTAAOMRAAPEI-201


title: S171_week_24-TB Subjects-140809_I266_FCC4MRWACXX_L3_RHUMjlxTAAOMRAAPEI-201


title: S171_week_4-TB Subjects-140809_I266_FCC4MRWACXX_L3_RHUMjlxTAAOLRAAPEI-227


title: S170_week_4-TB Subjects-140809_I266_FCC4MRWACXX_L2_RHUMjlxTAAOHRAAPEI-221


title: S170_week_24-TB Subjects-140809_I266_FCC4MRWACXX_L2_RHUMjlxTAAOIRAAPEI-222


title: S171_DX-TB Subjects-140809_I266_FCC4MRWACXX_L3_RHUMjlxTAAOJRAAPEI-223


title: S171_day_7-TB Subjects-140809_I266_FCC4MRWACXX_L3_RHUMjlxTAAOKRAAPEI-225


title: S171_day_7-TB Subjects-140809_I266_FCC4MRWACXX_L4_RHUMjlxTAAOKRAAPEI-225


title: S170_week_4-TB Subjects-140809_I266_FCC4MRWACXX_L1_RHUMjlxTAAOHRAAPEI-221


title: S170_week_24-TB Subjects-140809_I266_FCC4MRWACXX_L1_RHUMjlxTAAOIRAAPEI-222


title: S170_DX-TB Subjects-140809_I266_FCC4MRWACXX_L2_RHUMjlxTAAOFRAAPEI-219


title: S170_day_7-TB Subjects-140809_I266_FCC4MRWACXX_L2_RHUMjlxTAAOGRAAPEI-220


title: S169_week_24-TB Subjects-140809_I266_FCC4N1RACXX_L7_RHUMjlxTAAOERAAPEI-218


title: S169_week_4-TB Subjects-140809_I266_FCC4N1RACXX_L8_RHUMjlxTAAODRAAPEI-216


title: S170_DX-TB Subjects-140809_I266_FCC4MRWACXX_L1_RHUMjlxTAAOFRAAPEI-219


title: S169_week_24-TB Subjects-140809_I266_FCC4N1RACXX_L8_RHUMjlxTAAOERAAPEI-218


title: S170_day_7-TB Subjects-140809_I266_FCC4MRWACXX_L1_RHUMjlxTAAOGRAAPEI-220


title: S169_DX-TB Subjects-140809_I266_FCC4N1RACXX_L7_RHUMjlxTAAOBRAAPEI-214


title: S169_day_7-TB Subjects-140809_I266_FCC4N1RACXX_L8_RHUMjlxTAAOCRAAPEI-215


title: S169_DX-TB Subjects-140809_I266_FCC4N1RACXX_L8_RHUMjlxTAAOBRAAPEI-214


title: S171_week_4-TB Subjects-140809_I266_FCC4MRWACXX_L4_RHUMjlxTAAOLRAAPEI-227


title: S168_week_4-TB Subjects-140809_I266_FCC4N1RACXX_L6_RHUMjlxTAANZRAAPEI-212


title: S168_week_4-TB Subjects-140809_I266_FCC4N1RACXX_L4_RHUMjlxTAANZRAAPEI-212


title: S168_week_24-TB Subjects-140809_I266_FCC4N1RACXX_L6_RHUMjlxTAAOARAAPEI-213


title: S168_week_24-TB Subjects-140809_I266_FCC4N1RACXX_L4_RHUMjlxTAAOARAAPEI-213


title: S169_day_7-TB Subjects-140809_I266_FCC4N1RACXX_L7_RHUMjlxTAAOCRAAPEI-215


title: S168_DX-TB Subjects-140809_I266_FCC4N1RACXX_L4_RHUMjlxTAANXRAAPEI-210


title: S168_DX-TB Subjects-140809_I266_FCC4N1RACXX_L6_RHUMjlxTAANXRAAPEI-210


title: S167_week_4-TB Subjects-140809_I266_FCC4N1RACXX_L3_RHUMjlxTAANVRAAPEI-208


title: S167_week_24-TB Subjects-140809_I266_FCC4N1RACXX_L3_RHUMjlxTAANWRAAPEI-209


title: S167_week_24-TB Subjects-140809_I266_FCC4N1RACXX_L2_RHUMjlxTAANWRAAPEI-209


title: S167_DX-TB Subjects-140809_I266_FCC4N1RACXX_L3_RHUMjlxTAANTRAAPEI-206


title: S167_week_4-TB Subjects-140809_I266_FCC4N1RACXX_L2_RHUMjlxTAANVRAAPEI-208


title: S167_day_7-TB Subjects-140809_I266_FCC4N1RACXX_L2_RHUMjlxTAANURAAPEI-207


title: S167_day_7-TB Subjects-140809_I266_FCC4N1RACXX_L3_RHUMjlxTAANURAAPEI-207


title: S166_week_4-Lung Dx Controls-140809_I266_FCC4MRWACXX_L7_RHUMjlxTAAOORAAPEI-203


title: S166_week_4-Lung Dx Controls-140809_I266_FCC4MRWACXX_L6_RHUMjlxTAAOORAAPEI-203


title: S166_DX-Lung Dx Controls-140809_I266_FCC4MRWACXX_L7_RHUMjlxTAAONRAAPEI-202


title: S166_DX-Lung Dx Controls-140809_I266_FCC4MRWACXX_L6_RHUMjlxTAAONRAAPEI-202


title: S169_week_4-TB Subjects-140809_I266_FCC4N1RACXX_L7_RHUMjlxTAAODRAAPEI-216


title: S164_week_4-NA-140808_I162_FCC4N81ACXX_L8_RHUMjlxTAANRRAAPEI-204


title: S164_week_24-NA-140808_I162_FCC4N81ACXX_L8_RHUMjlxTAANSRAAPEI-205


title: S164_week_24-NA-140808_I162_FCC4N81ACXX_L7_RHUMjlxTAANSRAAPEI-205


title: S164_DX-NA-140808_I162_FCC4N81ACXX_L7_RHUMjlxTAANPRAAPEI-202


title: S164_day_7-NA-140808_I162_FCC4N81ACXX_L8_RHUMjlxTAANQRAAPEI-203


title: S164_day_7-NA-140808_I162_FCC4N81ACXX_L7_RHUMjlxTAANQRAAPEI-203


title: S164_DX-NA-140808_I162_FCC4N81ACXX_L8_RHUMjlxTAANPRAAPEI-202


title: S163_week_4-TB Subjects-140808_I162_FCC4N81ACXX_L4_RHUMjlxTAANNRAAPEI-227


title: S168_day_7-TB Subjects-140809_I266_FCC4N1RACXX_L4_RHUMjlxTAANYRAAPEI-211


title: S163_DX-TB Subjects-140808_I162_FCC4N81ACXX_L4_RHUMjlxTAANLRAAPEI-223


title: S168_day_7-TB Subjects-140809_I266_FCC4N1RACXX_L6_RHUMjlxTAANYRAAPEI-211


title: S163_day_7-TB Subjects-140808_I162_FCC4N81ACXX_L4_RHUMjlxTAANMRAAPEI-225


title: S167_DX-TB Subjects-140809_I266_FCC4N1RACXX_L2_RHUMjlxTAANTRAAPEI-206


title: S162_week_4-TB Subjects-140808_I162_FCC4N81ACXX_L3_RHUMjlxTAANJRAAPEI-221


title: S162_week_24-TB Subjects-140808_I162_FCC4N81ACXX_L3_RHUMjlxTAANKRAAPEI-222


title: S162_week_24-TB Subjects-140808_I162_FCC4N81ACXX_L2_RHUMjlxTAANKRAAPEI-222


title: S162_DX-TB Subjects-140808_I162_FCC4N81ACXX_L2_RHUMjlxTAANHRAAPEI-219


title: S162_day_7-TB Subjects-140808_I162_FCC4N81ACXX_L2_RHUMjlxTAANIRAAPEI-220


title: S161_week_4-TB Subjects-140808_I162_FCC4RDGACXX_L8_RHUMjlxTAANFRAAPEI-216


title: S161_week_24-TB Subjects-140808_I162_FCC4RDGACXX_L8_RHUMjlxTAANGRAAPEI-218


title: S161_week_4-TB Subjects-140808_I162_FCC4N81ACXX_L1_RHUMjlxTAANFRAAPEI-216


title: S161_week_24-TB Subjects-140808_I162_FCC4N81ACXX_L1_RHUMjlxTAANGRAAPEI-218


title: S163_week_4-TB Subjects-140808_I162_FCC4N81ACXX_L6_RHUMjlxTAANNRAAPEI-227


title: S161_day_7-TB Subjects-140808_I162_FCC4RDGACXX_L8_RHUMjlxTAANERAAPEI-215


title: S161_day_7-TB Subjects-140808_I162_FCC4N81ACXX_L1_RHUMjlxTAANERAAPEI-215


title: S163_week_24-TB Subjects-140808_I162_FCC4N81ACXX_L6_RHUMjlxTAANORAAPEI-201


title: S163_week_24-TB Subjects-140808_I162_FCC4N81ACXX_L4_RHUMjlxTAANORAAPEI-201


title: S160_week_4-TB Subjects-140808_I162_FCC4RDGACXX_L7_RHUMjlxTAANBRAAPEI-212


title: S163_day_7-TB Subjects-140808_I162_FCC4N81ACXX_L6_RHUMjlxTAANMRAAPEI-225


title: S163_DX-TB Subjects-140808_I162_FCC4N81ACXX_L6_RHUMjlxTAANLRAAPEI-223


title: S160_week_24-TB Subjects-140808_I162_FCC4RDGACXX_L7_RHUMjlxTAANCRAAPEI-213


title: S161_DX-TB Subjects-140808_I162_FCC4N81ACXX_L1_RHUMjlxTAANDRAAPEI-214


title: S160_DX-TB Subjects-140808_I162_FCC4RDGACXX_L6_RHUMjlxTAAMZRAAPEI-210


title: S160_week_24-TB Subjects-140808_I162_FCC4RDGACXX_L6_RHUMjlxTAANCRAAPEI-213


title: S162_week_4-TB Subjects-140808_I162_FCC4N81ACXX_L2_RHUMjlxTAANJRAAPEI-221


title: S160_DX-TB Subjects-140808_I162_FCC4RDGACXX_L7_RHUMjlxTAAMZRAAPEI-210


title: S160_day_7-TB Subjects-140808_I162_FCC4RDGACXX_L7_RHUMjlxTAANARAAPEI-211


title: S160_day_7-TB Subjects-140808_I162_FCC4RDGACXX_L6_RHUMjlxTAANARAAPEI-211


title: S160_week_4-TB Subjects-140808_I162_FCC4RDGACXX_L6_RHUMjlxTAANBRAAPEI-212


title: S159_week_4-TB Subjects-140808_I162_FCC4RDGACXX_L3_RHUMjlxTAAMXRAAPEI-208


title: S164_week_4-NA-140808_I162_FCC4N81ACXX_L7_RHUMjlxTAANRRAAPEI-204


title: S162_day_7-TB Subjects-140808_I162_FCC4N81ACXX_L3_RHUMjlxTAANIRAAPEI-220


title: S159_week_24-TB Subjects-140808_I162_FCC4RDGACXX_L4_RHUMjlxTAAMYRAAPEI-209


title: S159_week_24-TB Subjects-140808_I162_FCC4RDGACXX_L3_RHUMjlxTAAMYRAAPEI-209


title: S161_DX-TB Subjects-140808_I162_FCC4RDGACXX_L8_RHUMjlxTAANDRAAPEI-214


title: S159_DX-TB Subjects-140808_I162_FCC4RDGACXX_L3_RHUMjlxTAAMVRAAPEI-206


title: S159_day_7-TB Subjects-140808_I162_FCC4RDGACXX_L3_RHUMjlxTAAMWRAAPEI-207


title: S158_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L5_RHUMjlxTAAQSRAAPEI-211


title: S159_day_7-TB Subjects-140808_I162_FCC4RDGACXX_L4_RHUMjlxTAAMWRAAPEI-207


title: S158_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L5_RHUMjlxTAAQSRAAPEI-211


title: S159_DX-TB Subjects-140808_I162_FCC4RDGACXX_L4_RHUMjlxTAAMVRAAPEI-206


title: S158_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L6_RHUMjlxTAAQSRAAPEI-211


title: S156_week_24-TB Subjects-140808_I162_FCC4RDGACXX_L2_RHUMjlxTAAMURAAPEI-205


title: S157_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L5_RHUMjlxTAAQRRAAPEI-210


title: S158_DX-Healthy Controls-140809_I266_FCC4N1RACXX_L5_RHUMjlxTAAQSRAAPEI-211


title: S157_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L5_RHUMjlxTAAQRRAAPEI-210


title: S157_DX-Healthy Controls-140809_I266_FCC4N1RACXX_L5_RHUMjlxTAAQRRAAPEI-210


title: S156_week_4-TB Subjects-140808_I162_FCC4RDGACXX_L2_RHUMjlxTAAMTRAAPEI-204


title: S157_DX-Healthy Controls-140815_I272_FCC4MUGACXX_L6_RHUMjlxTAAQRRAAPEI-210


title: S156_week_24-TB Subjects-140808_I162_FCC4RDGACXX_L1_RHUMjlxTAAMURAAPEI-205


title: S156_DX-TB Subjects-140808_I162_FCC4RDGACXX_L2_RHUMjlxTAAMRRAAPEI-202


title: S156_day_7-TB Subjects-140808_I162_FCC4RDGACXX_L2_RHUMjlxTAAMSRAAPEI-203


title: S156_DX-TB Subjects-140808_I162_FCC4RDGACXX_L1_RHUMjlxTAAMRRAAPEI-202


title: S155_week_4-TB Subjects-140808_I269_FCC4MTUACXX_L8_RHUMjlxTAAMPRAAPEI-227


title: S155_week_24-TB Subjects-140808_I269_FCC4MTUACXX_L8_RHUMjlxTAAMQRAAPEI-201


title: S155_week_4-TB Subjects-140808_I269_FCC4MTUACXX_L7_RHUMjlxTAAMPRAAPEI-227


title: S155_week_24-TB Subjects-140808_I269_FCC4MTUACXX_L7_RHUMjlxTAAMQRAAPEI-201


title: S155_DX-TB Subjects-140808_I269_FCC4MTUACXX_L7_RHUMjlxTAAMNRAAPEI-223


title: S155_day_7-TB Subjects-140808_I269_FCC4MTUACXX_L8_RHUMjlxTAAMORAAPEI-225


title: S156_day_7-TB Subjects-140808_I162_FCC4RDGACXX_L1_RHUMjlxTAAMSRAAPEI-203


title: S155_DX-TB Subjects-140808_I269_FCC4MTUACXX_L8_RHUMjlxTAAMNRAAPEI-223


title: S154_week_4-TB Subjects-140808_I269_FCC4MTUACXX_L6_RHUMjlxTAAMLRAAPEI-221


title: S154_DX-TB Subjects-140808_I269_FCC4MTUACXX_L6_RHUMjlxTAAMJRAAPEI-219


title: S156_week_4-TB Subjects-140808_I162_FCC4RDGACXX_L1_RHUMjlxTAAMTRAAPEI-204


title: S155_day_7-TB Subjects-140808_I269_FCC4MTUACXX_L7_RHUMjlxTAAMORAAPEI-225


title: S154_week_24-TB Subjects-140808_I269_FCC4MTUACXX_L4_RHUMjlxTAAMMRAAPEI-222


title: S154_week_24-TB Subjects-140808_I269_FCC4MTUACXX_L6_RHUMjlxTAAMMRAAPEI-222


title: S154_week_4-TB Subjects-140808_I269_FCC4MTUACXX_L4_RHUMjlxTAAMLRAAPEI-221


title: S154_DX-TB Subjects-140808_I269_FCC4MTUACXX_L4_RHUMjlxTAAMJRAAPEI-219


title: S162_DX-TB Subjects-140808_I162_FCC4N81ACXX_L3_RHUMjlxTAANHRAAPEI-219


title: S154_day_7-TB Subjects-140808_I269_FCC4MTUACXX_L6_RHUMjlxTAAMKRAAPEI-220


title: S153_week_24-TB Subjects-140808_I269_FCC4MTUACXX_L2_RHUMjlxTAAMIRAAPEI-218


title: S153_week_4-TB Subjects-140808_I269_FCC4MTUACXX_L2_RHUMjlxTAAMHRAAPEI-216


title: S154_day_7-TB Subjects-140808_I269_FCC4MTUACXX_L4_RHUMjlxTAAMKRAAPEI-220


title: S153_DX-TB Subjects-140808_I269_FCC4MTUACXX_L3_RHUMjlxTAAMFRAAPEI-214


title: S153_week_4-TB Subjects-140808_I269_FCC4MTUACXX_L3_RHUMjlxTAAMHRAAPEI-216


title: S153_week_24-TB Subjects-140808_I269_FCC4MTUACXX_L3_RHUMjlxTAAMIRAAPEI-218


title: S153_DX-TB Subjects-140808_I269_FCC4MTUACXX_L2_RHUMjlxTAAMFRAAPEI-214


title: S153_day_7-TB Subjects-140808_I269_FCC4MTUACXX_L2_RHUMjlxTAAMGRAAPEI-215


title: S153_day_7-TB Subjects-140808_I269_FCC4MTUACXX_L3_RHUMjlxTAAMGRAAPEI-215


title: S152_week_4-TB Subjects-140808_I269_FCC4MG0ACXX_L6_RHUMjlxTAAMERAAPEI-213


title: S152_DX-TB Subjects-140808_I269_FCC4MG0ACXX_L6_RHUMjlxTAAMCRAAPEI-211


title: S150_week_4-TB Subjects-140808_I269_FCC4MG0ACXX_L4_RHUMjlxTAAMARAAPEI-209


title: S152_day_7-TB Subjects-140808_I269_FCC4MG0ACXX_L6_RHUMjlxTAAMDRAAPEI-212


title: S152_DX-TB Subjects-140808_I269_FCC4MG0ACXX_L7_RHUMjlxTAAMCRAAPEI-211


title: S150_week_24-TB Subjects-140808_I269_FCC4MG0ACXX_L7_RHUMjlxTAAMBRAAPEI-210


title: S152_day_7-TB Subjects-140808_I269_FCC4MG0ACXX_L7_RHUMjlxTAAMDRAAPEI-212


title: S150_week_24-TB Subjects-140808_I269_FCC4MG0ACXX_L6_RHUMjlxTAAMBRAAPEI-210


title: S150_DX-TB Subjects-140808_I269_FCC4MG0ACXX_L4_RHUMjlxTAALYRAAPEI-207


title: S150_DX-TB Subjects-140808_I269_FCC4MG0ACXX_L3_RHUMjlxTAALYRAAPEI-207


title: S150_day_7-TB Subjects-140808_I269_FCC4MG0ACXX_L4_RHUMjlxTAALZRAAPEI-208


title: S159_week_4-TB Subjects-140808_I162_FCC4RDGACXX_L4_RHUMjlxTAAMXRAAPEI-208


title: S150_day_7-TB Subjects-140808_I269_FCC4MG0ACXX_L3_RHUMjlxTAALZRAAPEI-208


title: S149_week_4-TB Subjects-140808_I269_FCC4MG0ACXX_L2_RHUMjlxTAALWRAAPEI-205


title: S152_week_4-TB Subjects-140808_I269_FCC4MG0ACXX_L7_RHUMjlxTAAMERAAPEI-213


title: S149_DX-TB Subjects-140808_I269_FCC4MG0ACXX_L1_RHUMjlxTAALURAAPEI-203


title: S149_day_7-TB Subjects-140808_I269_FCC4MG0ACXX_L1_RHUMjlxTAALVRAAPEI-204


title: S148_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L3_RHUMjlxTAAQQRAAPEI-209


title: S147_week_4-TB Subjects-140809_I266_FCC4N1RACXX_L1_RHUMjlxTAALSRAAPEI-201


title: S149_week_4-TB Subjects-140808_I269_FCC4MG0ACXX_L1_RHUMjlxTAALWRAAPEI-205


title: S149_day_7-TB Subjects-140808_I269_FCC4MG0ACXX_L2_RHUMjlxTAALVRAAPEI-204


title: S149_week_24-TB Subjects-140808_I269_FCC4MG0ACXX_L3_RHUMjlxTAALXRAAPEI-206


title: S147_week_4-TB Subjects-140805_I284_FCC4MV6ACXX_L8_RHUMjlxTAALSRAAPEI-201


title: S149_DX-TB Subjects-140808_I269_FCC4MG0ACXX_L2_RHUMjlxTAALURAAPEI-203


title: S147_DX-TB Subjects-140809_I266_FCC4N1RACXX_L1_RHUMjlxTAALQRAAPEI-225


title: S147_week_24-TB Subjects-140808_I269_FCC4MG0ACXX_L2_RHUMjlxTAALTRAAPEI-202


title: S147_day_7-TB Subjects-140809_I266_FCC4N1RACXX_L1_RHUMjlxTAALRRAAPEI-227


title: S147_DX-TB Subjects-140805_I284_FCC4MV6ACXX_L8_RHUMjlxTAALQRAAPEI-225


title: S147_week_24-TB Subjects-140808_I269_FCC4MG0ACXX_L1_RHUMjlxTAALTRAAPEI-202


title: S146_week_4-TB Subjects-140805_I284_FCC4MV6ACXX_L7_RHUMjlxTAALORAAPEI-222


title: S148_DX-Healthy Controls-140817_I162_FCC4MT4ACXX_L2_RHUMjlxTAAQQRAAPEI-209


title: S146_week_4-TB Subjects-140805_I284_FCC4MV6ACXX_L6_RHUMjlxTAALORAAPEI-222


title: S150_week_4-TB Subjects-140808_I269_FCC4MG0ACXX_L3_RHUMjlxTAAMARAAPEI-209


title: S146_week_24-TB Subjects-140805_I284_FCC4MV6ACXX_L8_RHUMjlxTAALPRAAPEI-223


title: S146_week_24-TB Subjects-140809_I266_FCC4N1RACXX_L1_RHUMjlxTAALPRAAPEI-223


title: S146_DX-TB Subjects-140805_I284_FCC4MV6ACXX_L7_RHUMjlxTAALMRAAPEI-220


title: S146_day_7-TB Subjects-140805_I284_FCC4MV6ACXX_L7_RHUMjlxTAALNRAAPEI-221


title: S149_week_24-TB Subjects-140808_I269_FCC4MG0ACXX_L4_RHUMjlxTAALXRAAPEI-206


title: S146_day_7-TB Subjects-140805_I284_FCC4MV6ACXX_L6_RHUMjlxTAALNRAAPEI-221


title: S145_week_24-TB Subjects-140805_I284_FCC4MV6ACXX_L7_RHUMjlxTAALLRAAPEI-219


title: S145_week_4-TB Subjects-140805_I284_FCC4MV6ACXX_L4_RHUMjlxTAALKRAAPEI-218


title: S145_week_4-TB Subjects-140805_I284_FCC4MV6ACXX_L3_RHUMjlxTAALKRAAPEI-218


title: S145_week_24-TB Subjects-140805_I284_FCC4MV6ACXX_L6_RHUMjlxTAALLRAAPEI-219


title: S146_DX-TB Subjects-140805_I284_FCC4MV6ACXX_L6_RHUMjlxTAALMRAAPEI-220


title: S144_day_7-TB Subjects-140805_I284_FCC4MV6ACXX_L2_RHUMjlxTAALGRAAPEI-213


title: S144_week_24-TB Subjects-140805_I284_FCC4MV6ACXX_L4_RHUMjlxTAALHRAAPEI-214


title: S145_DX-TB Subjects-140805_I284_FCC4MV6ACXX_L4_RHUMjlxTAALIRAAPEI-215


title: S145_day_7-TB Subjects-140805_I284_FCC4MV6ACXX_L4_RHUMjlxTAALJRAAPEI-216


title: S144_DX-TB Subjects-140805_I284_FCC4MV6ACXX_L2_RHUMjlxTAALFRAAPEI-212


title: S144_day_7-TB Subjects-140805_I284_FCC4MV6ACXX_L1_RHUMjlxTAALGRAAPEI-213


title: S144_week_24-TB Subjects-140805_I284_FCC4MV6ACXX_L3_RHUMjlxTAALHRAAPEI-214


title: S142_week_4-TB Subjects-140805_I284_FCC4MV6ACXX_L2_RHUMjlxTAALDRAAPEI-210


title: S144_DX-TB Subjects-140805_I284_FCC4MV6ACXX_L1_RHUMjlxTAALFRAAPEI-212


title: S142_week_4-TB Subjects-140805_I284_FCC4MV6ACXX_L1_RHUMjlxTAALDRAAPEI-210


title: S145_day_7-TB Subjects-140805_I284_FCC4MV6ACXX_L3_RHUMjlxTAALJRAAPEI-216


title: S142_week_24-TB Subjects-140805_I284_FCC4MV6ACXX_L1_RHUMjlxTAALERAAPEI-211


title: S142_DX-TB Subjects-140805_I284_FCC4MJAACXX_L7_RHUMjlxTAALBRAAPEI-208


title: S142_DX-TB Subjects-140805_I284_FCC4MJAACXX_L8_RHUMjlxTAALBRAAPEI-208


title: S142_week_24-TB Subjects-140805_I284_FCC4MV6ACXX_L2_RHUMjlxTAALERAAPEI-211


title: S142_day_7-TB Subjects-140805_I284_FCC4MJAACXX_L7_RHUMjlxTAALCRAAPEI-209


title: S142_day_7-TB Subjects-140805_I284_FCC4MJAACXX_L8_RHUMjlxTAALCRAAPEI-209


title: S147_day_7-TB Subjects-140805_I284_FCC4MV6ACXX_L8_RHUMjlxTAALRRAAPEI-227


title: S141_week_4-TB Subjects-140805_I284_FCC4MJAACXX_L7_RHUMjlxTAAKZRAAPEI-206


title: S141_week_24-TB Subjects-140805_I284_FCC4MJAACXX_L8_RHUMjlxTAALARAAPEI-207


title: S141_week_24-TB Subjects-140805_I284_FCC4MJAACXX_L7_RHUMjlxTAALARAAPEI-207


title: S141_DX-TB Subjects-140805_I284_FCC4MJAACXX_L6_RHUMjlxTAAKXRAAPEI-204


title: S145_DX-TB Subjects-140805_I284_FCC4MV6ACXX_L3_RHUMjlxTAALIRAAPEI-215


title: S141_DX-TB Subjects-140805_I284_FCC4MJAACXX_L4_RHUMjlxTAAKXRAAPEI-204


title: S141_day_7-TB Subjects-140805_I284_FCC4MJAACXX_L4_RHUMjlxTAAKYRAAPEI-205


title: S141_day_7-TB Subjects-140805_I284_FCC4MJAACXX_L6_RHUMjlxTAAKYRAAPEI-205


title: S140_week_4-TB Subjects-140805_I284_FCC4MJAACXX_L6_RHUMjlxTAAKVRAAPEI-202